Next Article in Journal
Nutritional, Therapeutic, and Functional Food Perspectives of Kale (Brassica oleracea var. acephala): An Integrative Review
Previous Article in Journal
Fe-Doped Nickel Carbonate Hydroxide-Supported Ru Nanocluster Catalyst as Efficient OER Electrocatalysts
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cyclophane-Based Dendrimers: Today and Tomorrow

A.M. Butlerov Chemical Institute, Kazan Federal University, Kremlevskaya St., 18, 420008 Kazan, Russia
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(21), 4211; https://doi.org/10.3390/molecules30214211
Submission received: 22 September 2025 / Revised: 20 October 2025 / Accepted: 24 October 2025 / Published: 28 October 2025

Abstract

For decades, dendrimers have attracted the great interest of researchers, and continue to do so to this day. These compounds found a wide variety of applications in such areas as medicine, catalysis, and electronics. However, their synthesis is very expensive, and purification and isolation are difficult. In addition, dendrimers are often highly toxic. Toxic properties are significantly dependent on the generation and terminal group features. For the toxicity, decreasing the modification of dendrimer structure is widely used. This review discusses some examples of constructing dendrimers based on macrocyclic compounds—cyclophanes (pillararenes, resorcinarenes, and (thia)calixarenes). Preparation of these hybrids is not very difficult, and due to the presence of a hydrophobic macrocyclic platform, they acquire a number of practically useful properties that are not available to traditional dendrimers, such as additional opportunities for encapsulating substrates. Moreover, dendrimers acquire amphiphilic and chiral properties. This review is devoted to the features of the synthesis and properties of macrocyclic dendrimers based on cyclophanes. The review also demonstrates the prospects of using the resulting dendrimers for medicine, sensorics, catalysis and alternative energy sources.

Graphical Abstract

1. Introduction

The history of dendrimer chemistry goes back more than forty years. It began in 1978 when F. Vögtle and colleagues published the description of the synthesis of “cascade molecules” [1]. Dendrimer chemistry was significantly advanced with the works of D. A. Tomalia [2,3], who was also the author of the “dendrimer” term itself. Dendrimers are nanosized radially symmetrical synthetic macromolecules with definite homogeneous and monodisperse structure. These compounds have symmetrical branched units, usually named “branches”, which are placed around the cylindric or linear core, so having a structure similar to a tree [4,5,6]. The word “dendrimers” originates from the Greek words “dendron”, which means tree-like, and “meros”, which means part or unit. During all these decades, a great scientific interest in this class of polymer compounds constantly remained. To date, a voluminous data set about the synthesis and application of a wide variety of dendrimers has been accumulated. This resulted in a huge number of literature reviews describing both the synthesis and application aspects of dendrimer chemistry due to the wide range of the attractive properties of these compounds. Considering that these compounds are analogous to polymers, the dendrimers can go beyond them due to their strictly defined and symmetrical structure and monodispersity. Such properties are provided by an important synthetic feature of this type of polymer: the growth of the molecule occurs as a result of completely controlled processes [7]. In addition to dendrimers widely used for catalysis, they can also be proposed as drug delivery agents, contrast agents for magnetic resonance imaging (MRI), transfection agents, etc. [8,9]. Such a diverse application of these hyperbranched compounds is due to their wide possibilities of binding a wide variety of compounds. This binding can occur both in the internal cavities of dendrimers (encapsulation) and via terminal functional groups. Covalent binding with prodrugs can also be used, along with the formation of entire ensembles of dendrimers and guest molecules [10]. Having a large number of terminal and internal functional groups, dendrimers have the ability to take part in multifunctional interactions. It allows them to bind the multifunctional biomolecules, such as proteins and DNA with the following so-called dendriplexes formation, which is useful for biopolymer delivery into living cells [11,12]. Another important property of dendrimers, namely their high solubility in water, determines their attractiveness for medical applications [13]. In the presence of a wide range of binding groups, such solubility can dramatically facilitate the hydrophobic drugs used in biological fluids. Currently, a number of dendrimers have already been tested clinically, and now they are patented as drug delivery agents [14]. Thus, the Australian company Starpharma has a series of patents for using of the dendrimers in pharmaceuticals [15]. At the same time, these compounds have some disadvantages limiting their practical application. So, usually dendrimers have high cytotoxicity, and their production is too expensive, especially those ones with high generations [16]. However, the functionalization of dendrimers often aimed to reduce their insufficient properties’ effect [17].
A promising direction for dendrimer modification is their combination with macrocyclic compounds [18]. Different macrocycles have found wide applications in medicine. Today, there is a large number of drugs based on them and now these compounds are studied extensively [19]. There are antitumor and antimicrobial drugs, immunosuppressors, as well as drugs for the treatment of autoimmune disorders among them [20]. The high demand for macrocycles in medicine is due to their attractive properties. Due to their structure, these compounds can strictly fix the binding centers, which allows them to enhance the selectivity of their binding to targets with complex geometry (large flat, groove-shaped, or tunnel-shaped), which cannot be accessed by conventional non-cyclic molecules. As a rule, natural macrocycles, namely oligopeptides, are produced by living organisms, and can be used as drugs. Synthetic macrocycles are usually obtained by natural analog modifying, which results in their properties’ improvement [21,22]. Carbohydrate compounds, in particular, cyclodextrins, are widely used. For example, the drug Sugammadex (tradename Bridion®) is used in surgery to relieve neuromuscular blockade [23]. Currently, medicinal chemists are still trying to obtain the analogs of other macrocycles, such as pillar[n]arenes, calix[n]arenes, terphen[n]arene, which are capable of binding the neuromuscular blocking agent [24,25,26,27]. In general, the growing interest in macrocycles, as well as in dendrimers, has not waned for many decades since the time of their discovery [28,29]. In addition to their application in medicine, they can be used in different areas: food industry, nanotechnology, catalysis, and also as chemical sensors, as selective extraction agents, etc. [30,31,32,33,34,35,36,37,38]. As a result of the long-term investigation of different types of macrocyclic compounds, the efficient approaches to their functionalization have been developed already. The simplicity of macrocycles’ modification and the presence of a number of functional groups make the prospects for their applications obvious—for example, as the core of dendrimers, as well as terminal groups or branching nodes. Moreover, using macrocyclic compounds in the design of dendrimers gives additional possibilities for binding various substrates. As a result, alongside the terminal groups and internal cavities of dendrimers, the cavity of the macrocycle itself can also be involved in complex formation. One of the most numerous groups of promising macrocyclic compounds are cyclophanes, such as (thia)calixarenes, resorcinarenes and pillararenes [39,40,41,42] (Figure 1). Their popularity among researchers is provided by several reasons simultaneously. The conformational diversity of (thia)calixarenes and resorcinarenes makes it easy to obtain a wide variety of compounds with the groups which are spatially located in a strictly defined way due to the macrocycle lower rim functionalization. This is the reason for multivalent effect occurrence [43]. The cyclophane platforms themselves are hydrophobic, so the ease of their functionalization makes it possible to obtain a set of compounds with any hydrophilic–hydrophobic balance required.
Dendrimers with macrocyclic (cyclophane) components, no matter if they are the cores or the fragments of branches, have another fundamental difference from the conventional ones. They can be classified as biomimetic systems. These dendrimers demonstrate such properties due to their unique structure. For example, pillararenes are well-known for their planar chirality [44]. Although the production of such compounds is rather complicated due to the rotation of phenylene groups around the bridging methylene fragments, there are many approaches to the production and separation of chiral pillararenes developed [45]. Resorcinarenes obtained within the condensation reaction of resorcinol with aliphatic and aromatic aldehydes, also have chiral properties in some conformations [41]. It is known that chiral molecules (amino acids, sugars, as well as proteins, nucleic acids, hormones and enzymes based on them) are the vital compounds on Earth [46,47]. Thus, if conventional dendrimers require the functionalization with appropriate groups to impart chiral properties, the cyclophane macrocycles have chiral properties due to geometric characteristics of the platform already. All of this provides their ability of selective binding to chiral biomolecules. Such a feature opens up excellent prospects for using macrocyclic dendrimers as catalysts for both asymmetric synthesis and medical technologies.
In this review, the dendrimers containing macrocyclic cyclophane fragments as cores or as surface functions are discussed. The examples of cyclophane dendrimers formed by supramolecular interactions between macrocyclic fragments and other groups (similar to tectodendrimers) are also given [48]. Special attention is paid to the prospects of the application of these hybrid molecules for various branches of industry and science.

2. Dendrimers with Cyclophane Fragments as a Core

2.1. Dendrimers Based on Pillararenes

As noted above, macrocyclic fragments can be promising as dendrimer cores. Macrocycles with functionalized groups are excellent templates to obtain branched molecules providing a shape which is close to spherical. In addition, macrocyclic compounds have the cavity for guest binding, which provides products with the properties of selective complexing agents. The most convenient way to investigate macrocyclic dendrimers is to become acquainted with the youngest and still a small class of compounds named pillararenes. This class appeared much later than the (thia)calixarenes and resorcinarenes described above [42,49] but it attracts the attention of many researchers nowadays. These macrocycles have great potential as complexing agents, while a large number of functionalized hydroxyl groups (ten) allow us to obtain products with good solubility in aqueous medium [50,51]. An important feature of pillararenes is their planar chirality which demonstrates good water solubility along with broad prospects for the application in biomedical technologies. Currently, only a few examples of dendrimers based on this class of cyclophanes are presented in the literature but they have already satisfied expectations. Thus, the first representatives of dendrimers based on pillar[5]arene 25 were obtained in 2013 by the convergent method upon the copper-catalyzed alkyne–azide cycloaddition (CuAAC) reaction from 1 (Scheme 1).
Derivatives of the first and second generations 2 and 3 with dendrons based on peripheral benzyloxycarbonyl (Boc)-protected amine sub-units on both the rims of the macrocycle were obtained in high yields (81 and 88%, respectively) [52]. Then, the protective groups were quantitatively removed with a large excess of trifluoroacetic acid. The resulting dendrimers 4 and 5 were capable of binding plasmid DNA (pCMVLuc) with the following stable positively charged particle formation. These polyplexes were evaluated in 5% glucose or 150 mM NaCl aqueous solutions and tested in vitro on HeLa cells. It turned out that in glucose solutions, they had the optimal sizes for cellular uptake (up to 60 nm). At the same time, the particle sizes in 150 mM NaCl were significantly larger (up to 930 nm).
The first-generation dendrimers with peripheral sugar residues were obtained similarly [53]. However, in this case the conjugation of macrocyclic deca-azide 6 was carried out with a series of propargylated derivatives provided from the acetylated glycoclusters 7 and 8 (Scheme 2).
Initially, acetyl derivatives were obtained with yields of up to 77%. Subsequent deprotection of the acetate ester moieties led to the obtaining of water-soluble glycoclusters 9 and 10 with yields of up to 84%, which were capable of binding Pathogenic Bacterial Lectins (LecB from Pseudomonas aeruginosa and BambL from Burkholderia ambifaria). It is important to note that the obtained dendrimer derivatives go beyond the unbranched analogs with binding capacity. Increasing affinity for lectins can also be achieved by varying the length of the spacer between the carbohydrate fragments and the macrocyclic core.
Pillararenes are efficient electron transfer mediators [54]. Their combination with triarylamine [55] allowed the researchers to obtain first- and second-generation dendrimers 11 and 12 with satisfactory yields of 50 and 55%, respectively, (Figure 2). These multi-branched molecules were proposed as the charge transferring materials within the fields of perovskite solar cells [56]. The resulting compounds absorbed in the visible region of spectrum and the cells based on them could afford power conversion efficiency of 16.5% for the second-generation dendrimer and 10% for the first-generation ones, respectively.

2.2. Dendrimers Based on Resorcinarenes

So far, significant progress has been made in the synthesis of calixresorcinarene-based dendrimers [41]. The history of resorcinarenes comprises more than one and a half century, so all of their properties have been studied rather profoundly during this period [57,58]. The bowl-shaped form of resorcinarenes provides their rigid framework and pre-organizes the surface, giving it a concave shape. This feature became the reason for the excellent binding properties of these compounds and allowed them to imitate the molecular recognition properties of enzymes [59]. Similarly to pillararene, the macrocyclic platform of resorcinarene has chirality which appears in a number of conformers. Optical activity of the macrocycles was provided by the asymmetric bridge carbon atom [41]. Contrary to the pillararenes, the control of chiral resorcinarenes synthesis was better developed. Stepwise functionalization using chiral catalysts or solvent-controlled conformational changes is widely used for these purposes [60,61,62]. The presence of two hydroxyl groups in the resorcinol molecule allows the researchers to obtain the dendrimers with a large number of branches based on resorcinarenes, whereas the functionalization of macrocycle hydroxyl groups creates the first branching. Dendrimers of the first-third generations with terminal n-propyl and allyl fragments 1315 synthesized on the base of resorcinarene by the convergent method were able to form complexes with fullerene C60 due to the implementation of strong π-π, CH-π and n-π interactions (Figure 3) [63,64].
First-generation poly(amidoamine) (PAMAM) dendrimers with a calixresorcinarene core 20 and 21 were obtained by a divergent method via the O-alkylation of resorcinarenes 16 and 17 with methyl bromoacetate followed by the treatment of the resulting products 18 and 19 with 1,2-diaminoethane (Scheme 3).
Branching in the second-generation dendrimers was initialized by the reaction of the amines obtained with methyl acrylate [65] (Scheme 4). The resulting PAMAM dendrimers 24 and 25 were used to impregnate a nylon membrane with a pore size of 0.45 μm which turned out to be efficient for divalent metal (Cu2+ and Ni2+) binding.
Mexican researchers have established some interesting prospects for resorcinarene core dendrimers’ application in cancer therapy. Functionalization of the terminal amino groups of the first- and second-generation PAMAM dendrimers (26 and 27, respectively) by 5-aryl-1,4-benzodiazepines groups (28 and 29) possessing anticancer activity [66] allowed to obtain 3033 with good yields (84–89%). The dendrimers synthesized appeared to be efficient anticancer agents [67] (Scheme 5). Compound 31 (the first generation containing 16 diazepine fragments with a chloro-substituent in the second ring of the 5-aryl-1,4-benzodiazepine group) was found to be the most efficient agent against prostatic adenocarcinoma, colorectal adenocarcinoma and lung adenocarcinoma in humans. Reducing the chlorine atom numbers (compound 30) led to a more than double decrease of the cytotoxicity. Interestingly, even the first- and second-generation dendrimers (26 and 27, respectively) without diazepine groups have demonstrated good anticancer properties.
Analogs of dendrimers 3033 with ibuprofen which are other drugs with anticancer properties [68,69] were obtained by boiling ibuprofen with dendrimers containing terminal amino groups in good yields, too (70% for the second generation 36, 37 and 90–95% for the first generation 34, 35, respectively, Figure 4) [70]. These compounds turned out to be almost nontoxic for healthy cells (human gingival fibroblast cell line), while being very efficient against other cancer cell lines (human glioblastoma, human prostatic adenocarcinoma, human chronic myelogenous leukemia cells, human mammary adenocarcinoma). The second-generation dendrimer with 16 ibuprofen fragments 37 bearing an aromatic substituent at the methylene carbon atom of the macrocycle had the highest selectivity towards cancer cells. Cellular internalization of the resorcinarene conjugate with ibuprofen was achieved apparently via clathrin-mediated endocytosis. The release of ibuprofen as a result of hydrolysis occurred rather slowly and strongly depended on the length of the branches in the dendrimer, reaching 80% in the case of the second generation.
Chorambucil moieties were also put into resorcinarene dendrimers as terminal fragments using the methods described above (Figure 5) [71]. The first generation was obtained with good yields (71-85%), while the synthesis of the second generation was more complicated (32–52%). Such a significant difference between the yields of the first and second generations can be decreased in future, as it was obviously provided by the elimination of the protocol drawbacks. Thus, steric factors must not significantly influence the reaction process which was demonstrated in the work [67].
The resulting dendrimers 3841 were efficient against human chronic myelogenous leukemia cells. Their activity was comparable to that of cisplatin, while these conjugates were less toxic towards the human gingival fibroblast cell line.
Diethylenetriamine was successfully used as an amine component [72] for creating the PAMAM dendrimer branches. This compound was used for the aminolysis of resorcinarene pre-functionalized with methyl bromoacetate at its hydroxyl groups. This method allowed the researchers to obtain first-generation dendrimers 42, 43 with excellent yields up to 95% (Scheme 6). For second-generation synthesis, the authors used a conventional approach, namely the Michael addition of methyl acrylate in methanol, to obtain the one-and-a-half generation 44, 45. As a result, second-generation dendrimers 46, 47 were also obtained by the interaction with diethylenetriamine in very good yields reaching 91%. However, the authors did not stop at these products but used them to synthesize metallodendrimers. Thus, the dendrimers obtained were involved in the reaction with ferrocene carboxylic acid 48 in methanol/benzene 1:1 at reflux (Scheme 7). The target metallodendrimers 4952 were synthesized in good yields (86–91%). The authors considered the dendrimers obtained to be promising ones for optoelectronic applications, since they were capable of fluorescence in the UV and visible ranges, while their spectrum characteristics significantly depended on the number of ferrocene fragments in the molecule.
Introduction of flutamide instead of ferrocene groups as terminal groups in PAMAM dendrimers with a resorcinarene core 42, 43, 46, 47 [73] allowed the researchers to obtain first- and second-generation dendrimers with sufficient anticancer properties. The conjugates were obtained by introducing the flutamide ether derivative 53 to the dendrimer amino groups but compared to the ferrocene derivatives the yields of the target products 5457 were lower (9–20%) (Scheme 8). The resulting conjugates (especially the second-generation dendrimer bearing 64 flutamide fragments) were efficient against three cancer cell lines, such as malignant glioblastoma, prostate adenocarcinoma and chronic myelogenous leukemia, also having low toxicity towards healthy cells. The mechanism of their action was explained by rather easy amide bond hydrolysis which provided the consequent release of the drug. It is important to note that the conjugation of flutamide with dendrimers improved its cytotoxic effect compared with unmodified flutamide, and reduced some undesirable effects.
Another interesting approach to the synthesis of resorcinol dendrimers was proposed by the authors of [74]. In this work, the dendron fragments were introduced to the dendrimer from the aldehyde component during the synthesis of the macrocyclic core itself. So, the resulting dendrimer had the branches linking to the core not by the oxygen atom of the resorcinol group but by a bridging methylene group (Scheme 9). The method was based on the condensation reaction of resorcinol 58 or 2-methylresorcinol 59 with the dendron 60 by boiling in chloroform in the presence of trifluoroacetic acid. Target dendrimers 61 and 62 were obtained in good yields of 87–88%.

2.3. Dendrimers Based on (Thia)Calixarenes

Today, the most thoroughly studied class of macrocyclic cyclophane dendrimers are the compounds with a (thia)calixarene core [75,76,77,78,79,80,81]. (Thia)calixarenes are the analogs of resorcinarenes with the macrocyclic platform formed with phenolic units [39,40]. They also have a bowl-shaped form and can exist in several spatial conformations, but their platform itself has no chiral properties. Nevertheless, pre-organization of the substituents around the (thia)calixarene platform and their rigid spatial localization allow them to recognize various biosystems selectively [82] including modulating enzyme activity assessment [83,84]. It is worth noting that such an effect of those (thia)calixarene derivatives without dendron fragments also remained the same in dendrimer analogs. It is interesting that the generation value does not significantly affect the binding efficiency of macrocyclic dendrimers based on thiacalix[4]arene. Thus, using the example of the hybrid PAMAM dendrimer with a thiacalixarene cycle (PAMAM-calix-dendrimers) of the first and second generations 6368, it was shown they could bind a number of catecholamines (dopamine, adrenaline and noradrenaline), while the binding efficiency was hardly dependent on generation (Figure 6). Interestingly, the monomeric analog was incapable of binding catecholamines. Thus, the template effect of the macrocycle played the key role in the formation of the complexation ability of PAMAM-dendrimer hybrids with a thiacalixarene macrocyclic fragments, which allows the binding groups re-localization to implement the multivalent effect [85]. The most significant contribution to the complexation process was made by the H-bonds formation, as well as van der Waals forces. In addition, the binding was affected by the size of internal cavities in the dendron fragments. Presumably, the complexation was predominantly carried out by the amino groups located in the internal cavities of the dendrimers, rather than the terminal ones. It was evidenced by both the data of two-dimensional 1H-1H NOESY NMR spectroscopy and the absence of noticeable affects of dendrimer generation on the binding efficiency. Previously, the macrocyclic platform of thiacalix[4]arene was shown to contribute to hormone-binding significantly [86].
The (thia)calixarene platform advantages for the design of dendrimers appeared as unexpected decreasing of the hemolytic activity of dendrimers with the growth of generation [85,87], which fundamentally distinguishes them from the conventional dendrimers [88,89]. In case of the thiacalixarene core, the hemolytic activity strongly depends on the macrocycle conformation having maximum value for the cone stereoisomer (63, Figure 6). This can be explained by the higher density of the cationic charge, which is distributed unevenly throughout the nanoparticle and accumulated on one side of the macrocyclic platform. Consequently, the enhancement of negative effects when interacting with red blood cells took place. 1,3-alternate Stereoisomer 71 (1,3-alternate) has the least hemolytic activity, as the charge density is the most uniformly distributed in its associates (Figure 7). The work [87] described the inability of third generation dendronized thiacalix[4]arenes 6971 to induce platelet aggregation: apar from having no interaction with platelets, they also did not hinder the contribution of all coagulation factors.
It is well known that dendrimers are capable of binding biopolymers, in particular DNA. As a rule, only conventional high generation dendrimers which are usually cytotoxic can bind DNA. The choice of thiacalixarene core as the platform has allowed researchers to bind DNA from salmon sperm and calf thymus with the first generation already (6365, 72, 73, Figure 6 and Figure 8) [90,91,92].
It was interesting that first-generation dendrimer 63 with a core of cone conformation, as a result of binding the biopolymer, has exerted the effect of stabilization preventing the biomolecule degradation in buffer solution. Such a core conformation effect was suggested to occur due to the isolation of the lipophilic (hydrophobic) part of the biopolymer amphiphilic compound from the aqueous solution. There was no such feature observed for the other conformations (partial cone and 1,3-alternate, 64 and 65) [90]. Interestingly, the complexation of calix-dendrimers 65, 68 and 71 based on the macrocyclic core in 1,3-alternate conformation with small interfering RNAs (siRNAs) protected siRNAs from degradation in the presence of RNases and serum proteins [93]. The resulting positively charged complexes were often used to deliver genetic material into cancer cells, increasing the cellular take-up of siRNAs significantly [94]. This ability of calix-dendrimers may find application in new anticancer drug designs. With generation growth, the binding abilities towards the biopolymers (namely DNA) certainly increased [87]. In this case, the macrocyclic platform conformation influencing the binding process has almost disappeared. The secondary structure of DNA remained unchanged during the interaction with all conformational isomers of PAMAM-calix-dendrimers. The interaction of calix-dendrimers with DNA did not limit the access of small molecules to the biopolymer. Thereby the process of their binding was used as a platform for the electrochemical DNA sensor which allowed the determination of the intercalator drug doxorubicin with a limit of detection equal to 10 pM [95] (Figure 9). The widening of the PAMAM-calix-dendrimer range was investigated and the analysis conditions optimization allowed researchers to improve the detection limit up to 1 pM [96]. These sensors contained the assembly of thiacalix[4]arene-based dendrimers in cone, partial cone, or 1,3-alternate conformation on the glassy carbon electrode surface coated with carbon black or multiwalled carbon nanotubes, where the DNA layer was additionally applied via electrostatic interactions (Figure 10). Choosing the conformation of the macrocyclic core has allowed researchers to form differently charged complexes with DNA (positive, negative and neutral), which can be used to determine various types of low-molecular substrates.
The structure of the stable complex of thiacalixarene 74 containing terminal ammonium groups with double stranded palindromic DNA decamer d(GCGTTAACGC)2 was determined using molecular docking and NMR spectroscopy methods (Figure 11) [91]. This decamer was chosen as a model compound to simplify the spectral pattern. It turned out that thiacalixarene predominantly interacted with the central fragment of the decamer, mainly to the thymine fragment, and the tert-butyl protons of the dendrimer were brought close to the methyl group of thymine. Two variants of the complexes were considered using the molecular docking method, such as binding via the major and minor grooves of the oligonucleotide. Despite the values being close to each other for both the complexes, the authors preferred the interaction via the major groove, since this type of complex was in better agreement with the NOESY NMR spectroscopy data.
The combination of zero-second-generation PAMAM-calix-dendrimers 75, 63, 66 with pillararene 76 (efficient electron transfer mediator) and phenothiazine derivative 77 was used as the platform for electrochemical biosensor development (Figure 12) [54]. The role of calix-dendrimers in the sensor assembly was to increase the efficiency of phenothiazine derivative electropolymerization, as well as to prevent the inactivation of pillararene due to its oxidation product accumulation on carbon black surface. This biosensor allowed researchers to determine uric acid in the concentration range of 10 nM–20 μM with a limit of detection of 4 nM. It was shown that the determination was not interfered with by such components as dopamine, glucose, and ascorbic acid. The authors found that using higher (second) generation dendrimers made it possible to increase the currents recorded, thus enhancing the sensitivity of the sensor.
In addition to DNA, PAMAM calix-dendrimers can bind the proteins effectively. Thus, binding of dendrimers 6365 of the first generation with chicken egg lysozyme led to the formation of supramolecular complexes which enhanced the antibacterial action of the enzyme [97]. Interestingly, those classical PAMAM dendrimers with linear ethylenediamine core were capable of significant binding to lysozyme only for the third generation. It is worth noting here that using a conventional fifth-generation PAMAM dendrimer (with a 1,4-diaminobutane core, carbomethoxypyrrolidone-terminated) also provided the increasing of the antibacterial effect of histidine kinase inhibitor peptide [98] against a methicillin-resistant strain of Staphylococcus aureus [99]. When the ethylenediamine terminal fragments of the first-generation calix-dendrimers were replaced by anionic carboxylate fragments (compounds 7880), the ability to bind to lysozyme remained the same, and the macrocycle could stabilize the protein structure and inhibit its fibrillation [100] (Figure 13). The resulting associates had a nano- or submicron size, the minimal size was for the partial cone core conformation (84 nm) and the maximal for the 1,3-alternate (682 nm), respectively. The positive charge of the particles formed allowed the researchers to suggest the protein was located at their surface. Electron microscopy methods demonstrated the difference in the morphology of the associates definitely. In case of partial cone, there were small spherical particles at the images, while for 1,3-alternate, extended formations were observed representing the conglomerates of smaller particles.
Due to the functionalization of the thiacalixarene backbone with fragments structurally similar to choline, the authors [83] achieved PAMAM-calix-dendrimers binding to cholinesterase (butyryl- or acetyl-) which led to the inhibition of the enzyme (Figure 14).
Thus, the therapeutic effect of the new macrocyclic dendrimers 6365, 8186 can be expected towards Alzheimer’s disease and other neurodegenerative disorders [101,102]. Moreover, the therapeutic potential of calix-dendrimers is not limited by enzyme inhibition. Metacyclophanes are known as antibacterial agents [103] due to which their dendrimer derivatives also exhibited bactericidal properties [97,104]. It should be noted here that the bactericidal activity of PAMAM-calix-dendrimers was significantly higher than that of their traditional analogs with a linear core, as well as compared to monomeric analogs without the macrocyclic platform. If the dependence of antibacterial activity on the macrocyclic core conformation is taken into consideration, a definite pattern can be observed: the most active conformations were the cone and partial cone, in which the charge density on the particle surface was higher than the one of the 1,3-alternate. Thus, these conformations had the most effect on the bacterial cell membrane which led to its destruction. Additional experiments with model membranes confirmed the proposed mechanism. There was the greatest change in the model vesicles’ size for the partial cone observed, indicating their loosening in the presence of calix dendrimer (Figure 15). The greatest activity was specific for calix dendrimers bearing terminal tertiary amino groups [104].
A distinctive feature of calix-dendrimers is the first generation exhibiting the properties of standard thiacalixarenes, such as increasing the amphiphilicity of their structure in the range 1,3-alternate < partial cone < cone. Due to this property, the water solubility is usually maximum for the stereoisomer with cone conformation of the core [97]. For higher generations, the difference between various conformations was erased due to the shielding of the macrocyclic core by the branches. In general, the analysis of all currently available data on PAMAM-calix-dendrimers allowed the researchers to conclude that it was the dendrimer with the core in the cone conformation that formed self-associates with minimal (nanometer) size [85,105]. The other conformations (especially 1,3-alternate) form extended vesicles in solutions due to the branches placed at both sides of the macrocyclic core [106]. However, binding to various molecules, including biopolymers, usually led to the decreasing of the associates’ size compared to individual compounds [87,90,97]. This feature of calix-dendrimers makes them excellent candidates for drug delivery, since the small size of the complex is critically important for these purposes [107,108]. Small particles (30–200 nm) are not attacked by the body’s immune system, while they are large enough to be not excreted from the body by the kidneys. The sizes of calix-dendrimers, even in lower generations due to the presence of a macrocyclic platform, are comparable to the sizes of conventional high-generation dendrimers. Thus, the first generation of PAMAM-calix-dendrimers size corresponds to the fourth generation of PAMAM dendrimers with an ammonium core one [109,110]. The successful drug releasing from the complexes has been demonstrated using catecholamines as the example [85], which also confirmed the prospects of PAMAM-calix-dendrimers for drug delivery.
In 2009, the first-generation polyamine dendrimer derivative 74 based on p-tert-butylthiacalix[4]arene was presented, in which the branches were formed from N,N-dipropyliden-amine [110,111]. Its analog 87 with amino diacetate fragments outside was also obtained (Figure 16). The effect of both compounds on the dynamic structure of liposomal membranes made of dipalmitoyl phosphatidylcholine was studied. The authors have found the binding of calixarenes occurred predominantly in the polar region of the bilayer. The hydrophilic 74 interacted with phosphate groups. It was located close to the bilayer surface and had no visible effect on the transition temperature. At the same time, dendrimer 87 with terminal amino diacetate fragments formed the bridges between positively charged choline groups of neighboring lipid molecules at the bilayer surface, thereby promoting their denser packing and increasing the phase transition temperature.
The phosphorylation of terminal amino groups 74 and 88 by the Moedritzer–Irani method allowed the researchers to obtain first- and second-generation dendrimers based on thiacalixarene in the 1,3-alternate conformation with phosphonic acid fragments at the rim [112]. The following treatment of these products with aqueous ammonia led to the appropriate ammonium salts in excellent yields (94–96%) (Scheme 10). The phosphorylation itself proceeded in a good yield of 85% in the case of the first generation (compound 89); however, for the second generation, the results were significantly worse (43%), which was apparently because of a large loss of the target product 90 due to its high solubility in water.
Negatively charged first-generation macrocyclic 89 and 91 formed polydisperse associates in aqueous solution [113], which were found to bind dodecyl trimethyl ammonium chloride. In this case, polydisperse systems consisting of predominantly submicron-sized particles were also formed [114]. The guanidine derivative of thiacalix[4]arene 93 was chosen as the positively charged component in inter-polyelectrolyte complexes based on 89 and 91 (Figure 17). These complexes had lower polydispersity in solution, as well as nanometer sizes of the formed particles [113]. Also, the systems formed by 89 and 91 were stabilized in the presence of silver ions, which induced reversible association/dissociation of supramolecular aggregates [115]. The described inter-polyelectrolyte particles could bind lysozyme without changing its conformation.
For the thiacalix[4]arene derivatives, a divergent approach to synthesis with sequential increasing of the dendron length has been demonstrated to be excellent and allowed the researchers to obtain the target compounds in high yields [87] (Scheme 11). Amine derivatives of thiacalix[4]arene in various conformations were chosen as the cores. Methyl acrylate was used to initiate branching. It is important to note here that the key condition for the successful synthesis of target PAMAM-calix-dendrimers was the length of the aminoalkyl substituent of the core. Thus, with the length increasing, steric limitations were reduced, the probability of intra- and intermolecular cross-linking decreased, and the yields of target compounds increased significantly [116]. In the authors’ opinion, the optimal substituent in this case was hexamethylene spacer [86]. So-called half-generations 9496 obtained were converted into target compounds by aminolysis reaction. The authors of [117] had limited their investigation by the first-generation dendrimers with a single conformation of the thiacalixarene core (1,3-alternate). A completely different approach was used for their synthesis, such as the azide–alkyne click reaction (Scheme 12).
Di- and tetrapropargyl derivatives of 9799 were functionalized with previously formed gallic acid-based dendrons 100 by means of Cu-catalyzed azide–alkyne cycloaddition reaction (Scheme 12). As a result, symmetrical 103 and two amphiphilic dendrimers 101 and 102 were obtained with different lengths of the alkyl chains. Using of the convergent approach turned out to be very efficient, as the yields reached 65–89%, apparently due to the fairly free arrangement of the propargyl substituents in the 1,3-alternate conformation. All the dendrimers obtained were capable of submicron associates’ formation in water, and the most compact particles were formed by more lipophilic compounds due to the efficient hydrophobic interactions’ contribution. Dendrimer 103 with four dendrons was the largest one and formed the extended structures, which was in good agreement with the behavior of PAMAM-calix-dendrimers of 1,3-alternate conformation. All the dendrimers were able to bind the organic hydrophobic dye Orange OT. The highest solubilizing capacity was shown for amphiphilic 101 with butyl substituents, which provided sufficient loosening of associates. As a result, it allowed the dye to be incorporated into the hydrophobic layer of the aggregates. The ability to form nanoassociates was used to stabilize Pd nanoparticles in the Suzuki model cross-coupling reaction and to reduce p-nitrophenol. All dendrimer-stabilized Pd nanoparticles showed high catalytic activity. The stabilization occurred, apparently, due to the nanoparticles located in the dendrimer cavities, and their aggregation was prevented [8].
The introduction of imidazolium groups as terminal ones (Scheme 13) did not cancel the ability to bind the Orange OT dye, and also unchanged the catalytic activity of Pd nanoparticles for the reduction in p-nitroaromatic compounds [118]. Positively charged imidazolium groups provided new dendrimers 104106 with the ability to bind calf thymus DNA, which resulted in DNA compaction (with the maximum for symmetrical dendrimer 106 with four dendrons up to 100 nm). Binding occurred inside the aggregates via an electrostatic mechanism proved by recharging negative ctDNA to a positively charged one.
The convergent synthesis method was successfully extended to the classical analog of thiacalix[4]arene—calix[4]arene (Scheme 14) [119]. The CuAAC reaction method was used to obtain dendrimers of the first (109, 110, 112 and 113) and second (111 and 114) generations in satisfactory yields reaching 85% for the first and 48% for the second generations, respectively. All the dendrimers obtained formed nanometer associates in water with the constituent particles of 80–130 nm. The greater the number of hydrophilic substituents (dendrimers with four branches), the larger the size of the particles formed. The dendrimers obtained could also stabilize palladium nanoparticles which were subsequently used as the catalysts in the cross-coupling reaction between p-bromoanisole and phenylboronic acid in water. The stabilization of metal nanoparticles occurred due to their agglomeration hindrance when they were bound to dendrimers. Dendrimer-stabilized nanoparticles had lower catalytic activity compared to free nanoparticles and to stabilized PEH-16 polyol. The best conversion was observed in the case of more branched tetra-alkyl substituted calixarenes and at the concentrations above the critical micelle concentration (CMC) value. Dendrimers with oxyethyl substituents exhibited the highest selectivity, while hydroxydendrimers were significantly way below them in this regard. Side biphenyl was formed in their presence. Dendrimers with concentrations above their CMC also turned out to be efficient in the reaction of p-nitrophenol reduction. Stabilization of palladium nanoparticles with dendrimers was also used for the reduction in hydrophobic p-ethylnitrobenzene which, unlike p-nitrophenol, was practically insoluble in water. In this case, the second generation branched dendrimers showed worse results compared to the first-generation analogs due to the bulk hydrophilic branches preventing the metal nanoparticles from their approach close to the solubilized hydrophobic substrates.
Dendrimers 123126 with terminal ammonium groups at the upper rim were obtained by similar click reaction method using azide derivatives of calix[4]arene 115118 and propargylamines (Scheme 15) [120,121]. The resulting compounds have formed positively charged submicron associates in water (electrokinetic potentials of +40 ÷ +60 mV) with CMC significantly depending on the compound hydrophobicity. The replacement of two polar ammonium groups with tert-butyl groups (compounds 123 and 124) at the upper rim led to the decreasing of CMC from 790 to 5 μM [121]. The aggregates of 123, 124 and 125, 126 were able to bind negatively charged eosin Y dye, as they maintained a positive charge. The resulting complexes were used as the nucleotide probes whose action was based on competitive substitution of the dye for nucleotide. Interestingly, the most efficient binding was observed for disubstituted 123, 124 with the less charged adenosine-5’-diphosphate (ADP), rather than with adenosine-5’-triphosphate (ATP). The authors explained this behavior with a quantum chemical approach. The significantly larger size of ATP compared to ADP did not allow the former to achieve good geometrical coincidence with two ammonium fragments of the receptor. The method developed has provided the visual detection of ADP with a limit of detection equal to 0.5 mM.
The trend of the CMC decrease with growing hydrophobicity of the compounds also remained in the series of 125127 substituted with ammonium fragments at the upper rim (Scheme 15, Figure 18) [120]. For the most hydrophilic 127 with phenolic groups at the lower rim, the CMC was not determined. When phenolic groups were replaced by ethyl and tetradecyl fragments, the CMC reached 5.0 and 3.4 μM, respectively. In this case, the associates of the minimum size were formed for the most hydrophobic 126 (19 nm), while for 125 they had already become significantly larger (145 nm). All the dendrimers studied could bind calf thymus DNA by the intercalation mechanism, which was proved by the significant increase in DNA melting temperatures in their presence. The greatest increase in temperature was achieved for 126 (from 72.5 to 84.2 °C). Dendrimers binding with DNA led to its compaction which also turned out to be maximum in the case of 126 (22 nm).
The convergent synthesis method was also used to obtain some derivatives of classical calix[4]arene of cone conformation but there was no possibility to obtain any generations higher than the second one (Scheme 16) [122]. It should be noted that the yields of the target products were significantly lower than in the case of thiacalixarene (77% for the first generation (129), 68% for the second generation (131), respectively). Obviously, this was due to the smaller size of the classical platform and steric limitations of its functionalization. The fact that the authors chose the convergent route of functionalizing of rather a small macrocycle with bulky groups might also have the effect. Succinimide derivatives of p-tert-butyl-calix[4]arene 128 were chosen as a functionalized scaffold to which pyrrolidine derivatives were added. The acetamide fragments at the lower rim of the calixarene provided its ability to bind with alkali metal salts which in turn led to the rigid localization of the spatial structure of the dendrimer.
The authors of [123] succeeded to achieve higher yields. The researchers chose bis-propargyloxy-p-tert-butyl-calix[4]arene as the starting reagent (Scheme 17). Using a regioselective Cu-catalyzed alkyne–azide cycloaddition reaction, they have obtained calix[4]arene-appended glycodendrimers of the first and second generations with lactose (134) and galactose (136) fragments, respectively. The presence of two functionalized propargyl groups only significantly reduced steric hindrances, so the yield of the target glycodendrimers was quite high.
Using the divergent approach based on p-sulfonatocalix[4]arene 137, the second generation of macrocyclic dendrimer with terminal amino groups 139 was obtained (Scheme 18) [124]. The resulting dendrimer was combined with Fe3O4 to obtain magnetic nanoparticles, which were the promising tools for the diagnosis and treatment of various diseases [125]. The resulting assembly was characterized by the optimal size of the associates formed in water (about 100 nm). The simultaneous presence of the hydrophobic macrocyclic cavity and anionic sulfonate groups, as well as cationic ammonium fragments in the dendrimer, opens up great prospects for binding a wide variety of substrates. The resulting dendrimer was proposed as a dual-drug carrier for the co-delivery of Doxorubicin and Methotrexate to MCF7 breast cancer cells with targeting and synergistic effects. The simultaneous presence of alkali and acidic fragments provided the possibility of drug releasing depending on pH. One important advantage of these magnetic nanoparticles was their low hemolytic activity and cytotoxicity towards the MCF7 cell line. Nanovehicle binding to human plasma proteins provided its high susceptibility to incorporation into cancer cells due to the presence of protein receptors at their surface.

2.4. Dendrimers with Addition Cyclophane Fragments in the Branches

The dendrimers with macrocyclic compounds located at the periphery of the molecule are of great interest [126,127,128]. One exciting example is a hybrid multicyclophane molecule in which macrocycles are simultaneously presented both as a core (thiacalix[4]arene) and as the terminal fragments (pillar[5]arene) (Figure 19) [129]. The starting materials were acyl chlorides of p-tert-butylthiacalix[4]arene in the cone 140 and 1,3-alternate 141 conformations, which were used to acylate the monoamino derivative of pillar[5]arene 142. The target products 143 and 144 were obtained in satisfactory yields of 58 and 65%, respectively, (Scheme 19). The resulting compounds were capable of binding aniline and the salt of p-toluenesulfonic acid with aniline. The binding was performed with a pillararene fragment which could not bind p-toluenesulfonic acid in its pure form but could successfully bind the contact ion pair formed by p-toluenesulfonic acid and aniline forming an ensemble system. These properties provided the application of the obtained compounds for supramolecular assistance in aniline oxidative polymerization in aqueous p-toluenesulfonic acid solutions. In their presence, the yield of emeraldine increased from 50 to 90%. Simultaneously, its average molecular weight also increased. Hexa- and heptamer predominated among the polymerization products.
The multicyclophane with three terminal pillararene fragments 146 linked by amide linkers to a tris(2-aminoethyl)amine core was obtained in 62% yield (Scheme 20) [130]. The resulting compound could form the complex with N-phenyl-3-(phenylimino)-3H-phenothiazin-7-amine. Such complexation was accompanied by color change from pink for free phenothiazine to blue for the bound one. The phenothiazine dye color dependence on its environment was successfully used to create the colorimetric sensor for fluoride anion. The presence of fluoride in the solution led to the destruction of the multicyclophane complex with the dye followed by the formation of a new complex with the anion, whereas the color went back to pink upon phenothiazine releasing.

3. Supramolecular Cyclophane Dendrimers

Unfortunately, there were few investigations of supramolecular dendrimers based on cyclophanes. Thus, there are much more examples of macrocyclic dendrimers, whose formation occurred due to supramolecular interactions involving crown ethers and cyclodextrins [131,132,133]. At the same time, it is well known that pillararenes are able to form inclusion complexes with not quite bulky guests being fixed inside the cavity of the macrocycle. The formation of complexes occurs due to the negative electrostatic potential of pillararene. The polar guests can be embedded into the cavity if they have the charge distribution providing favorable electrostatic interactions with it [134]. The embedding of linear molecules with long alkyl fragments can be accompanied by the formation of pseudorotoxane structures [135]. This advantage of pillararenes was used by the authors of [136] to design supramolecular dendrimers based on pillar[5]arene 147. For this purpose, the macrocycles monosubstituted with dendron fragments with one (148) or two branches (149) were obtained (Scheme 21). The resulting dendronized macrocycles were separated using column chromatography in good yields (60 and 76% in the case of dendrons with two and one branches, respectively). The authors achieved their further self-assembly into dimeric and trimeric dendrimers using di- and tritopic connectors (150 and 151) with a pentanenitrile fragment, which has a high binding constant with pillar[5]arene [137]. The process of supramolecular self-assembly was investigated by 1H NMR spectroscopy. The resulting supramolecular dendrimers were easily destroyed when a competitive guest was added. It was found, in the presence of adiponitrile, that the pentanenitrile fragment was displaced from the macrocyclic cavity of complex 152 with the following adiponitrile inserting in its place (Figure 20).

4. Conclusions

Thus, today cyclophane derivatives (pillar-, resorcinol-, (thia)calixarenes) are intensively studied as the components of dendrimers: both cores and terminal fragments. The combination of the hydrophobic platform with polar substituents allows the use of dendronized cyclophane derivatives for both polar and lipophilic compound binding. The simplicity of the functionalization of macrocyclic platforms and the possibility of the rigid fixation of substituents related to them in combination with the chiral properties of macrocycles allow the high-precision and inexpensive synthesis of compounds capable of selective binding to biosystems and influencing their properties. The possibility of introducing a large number of fragments at once including pharmaceutically active ones should be noted as giving unlimited prospects for new drug designs. Both covalent binding and supramolecular interactions are used for this purpose. The ability of thiacalixarene-based macrocyclic dendrimers to form supramolecular systems with DNA is successfully used to develop the electrochemical sensors for drugs and metabolite determination. Substrate binding is mainly provided by the terminal groups of cyclophane dendrimers or by the cavities formed by their branches with the fixation of the lipophilic guest molecule near the macrocyclic platform. The macrocyclic platform itself is directly involved in binding only during the formation of supramolecular dendrimers. Thus, currently, only the most common macrocyclic platforms (pillar[5]-, (thia)calix[4]-, calix[4]resorcinarenes) have been studied in detail as components of dendrimers. However, there is no data about the dendrimers based on their homologs. A promising direction of research is to expand the homologous set of macrocycles in the design of dendrimers, which will allow the involvement of additional centers (the macrocyclic platform itself) in substrate binding and expand the spectrum of detectable guest molecules. Thus, gaining new knowledge regarding cyclophane-based dendrimers can have great contribution to the improvement of a variety of technologies including the fields of alternative energy, electronics, catalysis, the development of new diagnostic tools and drugs. We hope that the further development of the topic presented will show broad opportunities for the synthesis of new materials with currently unavailable useful properties.

Author Contributions

Conceptualization, O.M., A.V. and I.S.; software, A.G.; validation, A.V. and A.G.; formal analysis, O.M.; data curation, O.M.; writing—original draft preparation, O.M., A.V. and A.G.; writing—review and editing, I.S.; visualization, A.V. and A.G.; supervision, I.S.; project administration, I.S.; funding acquisition, I.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Russian Science Foundation, Russian Federation (grant 21-73-20067-P, “https://rscf.ru/en/project/21-73-20067/ (accessed on 28 May 2025)”).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Buhleir, E.; Wehner, W.; Vögtle, F. “Cascade”- and “Nonskid-Chain-like” Syntheses of Molecular Cavity Topologies. Synthesis 1978, 2, 155–158. [Google Scholar] [CrossRef]
  2. Tomalia, D.A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Roeck, J.; Ryder, J.; Smith, P. New Class of Polymers: Starburst-Dendritic Macromolecules. Polym. J. 1985, 17, 117–132. [Google Scholar] [CrossRef]
  3. Tomalia, D.A.; Nixon, L.S.; Hedstrand, D.M. The role of branch cell symmetry and other critical nanoscale design parameters in the determination of dendrimer encapsulation properties. Biomolecules 2020, 10, 642. [Google Scholar] [CrossRef]
  4. Gondkar, S.B.; Rasal, S.P.; Saudagar, R.B. Dendrimer: Asian J. Pharm. Res. 2016, 6, 188–192. [Google Scholar] [CrossRef]
  5. Patel, P.; Patel, V.; Patel, P.M. Synthetic strategy of dendrimers: A review. J. Indian Chem. Soc. 2022, 99, 100514. [Google Scholar] [CrossRef]
  6. Sarode, R.J.; Mahajan, H.S. Dendrimers for drug delivery: An overview of its classes, synthesis, and applications. J. Drug Deliv. Sci. Technol. 2024, 98, 105896. [Google Scholar] [CrossRef]
  7. Muzafarov, A.M.; Rebrov, Ε.A.; Papkov, V.S. Three-dimensionally growing polyorganosiloxanes. Possibilities of molecular construction in highly functional systems. Russ. Chem. Rev. 1991, 60, 807–814. [Google Scholar] [CrossRef]
  8. Karakhanov, E.; Maximov, A.; Zolotukhina, A. Heterogeneous Dendrimer-Based Catalysts. Polymers 2022, 14, 981. [Google Scholar] [CrossRef]
  9. Ortega, M.Á.; Merino, A.G.; Fraile-Martínez, O.; Recio-Ruiz, J.; Pekarek, L.; Guijarro, L.G.; García-Honduvilla, N.; Álvarez-Mon, M.; Buján, J.; García-Gallego, S. Dendrimers and Dendritic Materials: From Laboratory to Medical Practice in Infectious Diseases. Pharmaceutics 2020, 12, 874. [Google Scholar] [CrossRef] [PubMed]
  10. Wang, J.; Li, B.; Qiu, L.; Qiao, X.; Yang, H. Dendrimer-based drug delivery systems: History, challenges, and latest developments. J. Biol. Eng. 2022, 16, 18. [Google Scholar] [CrossRef]
  11. Astruc, D.; Boisselier, E.; Ornelas, C. Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine. Chem. Rev. 2010, 110, 1857–1959. [Google Scholar] [CrossRef]
  12. Li, L.; Deng, Y.; Zeng, Y.; Yan, B.; Deng, Y.; Zheng, Z.; Li, S.; Yang, Y.; Hao, J.; Xiao, X.; et al. The application advances of dendrimers in biomedical field. View 2023, 4, 20230023. [Google Scholar] [CrossRef]
  13. Beezer, A.E.; King, A.S.H.; Martin, I.K.; Mitchel, J.C.; Twyman, L.J.; Wain, C.F. Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives. Tetrahedron 2003, 59, 3873–3880. [Google Scholar] [CrossRef]
  14. Madaan, K.; Kumar, S.; Poonia, N.; Lather, V.; Pandita, D. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J. Pharm. Bioallied Sci. 2014, 6, 139–150. [Google Scholar] [CrossRef]
  15. Starpharma. Available online: https://www.starpharma.com/company (accessed on 11 August 2025).
  16. Labieniec-Watala, M.; Watala, C. PAMAM Dendrimers: Destined for Success or Doomed to Fail? Plain and Modified PAMAM Dendrimers in the Context of Biomedical Applications. J. Pharm. Sci. 2015, 104, 2–14. [Google Scholar] [CrossRef]
  17. Rana, A.; Adhikary, M.; Singh, P.K.; Das, B.C.; Bhatnagar, S. “Smart” drug delivery: A window to future of translational medicine. Front. Chem. 2022, 10, 1095598. [Google Scholar] [CrossRef] [PubMed]
  18. Caminade, A.-M.; Wei, Y.; Majoral, J.-P. Dendrimers and macrocycles: Reciprocal influence on the properties. Comptes Rendus Chim. 2009, 12, 105–120. [Google Scholar] [CrossRef]
  19. Wang, X.; Ma, L.; Li, C.; Yang, Y.-W. Macrocycle-Based Antibacterial Materials. Chem. Mater. 2024, 36, 2177–2193. [Google Scholar] [CrossRef]
  20. Jimenez, D.G.; Poongavanam, V.; Kihlberg, J. Macrocycles in Drug Discovery—Learning from the Past for the Future. J. Med. Chem. 2023, 66, 5377–5396. [Google Scholar] [CrossRef] [PubMed]
  21. Driggers, E.M.; Hale, S.P.; Lee, J.; Terrett, N.K. The exploration of macrocycles for drug discovery—An underexploited structural class. Nat. Rev. Drug Discov. 2008, 7, 608–624. [Google Scholar] [CrossRef] [PubMed]
  22. Stoikov, I.I.; Antipin, I.S.; Burilov, V.A.; Kurbangalieva, A.R.; Rostovskii, N.V.; Pankova, A.S.; Balova, I.A.; Remizov, Y.O.; Pevzner, L.M.; Petrov, M.L.; et al. Organic Chemistry in Russian Universities. Achievements of Recent Years. Russ. J. Org. Chem. 2024, 60, 1361–1584. [Google Scholar] [CrossRef]
  23. Nag, K.; Singh, D.R.; Shetti, A.N.; Kumar, H.; Sivashanmugam, T.; Parthasarathy, S. Sugammadex: A revolutionary drug in neuromuscular pharmacology. Anesth. Essays Res. 2013, 7, 302–306. [Google Scholar] [CrossRef]
  24. Shurpik, D.N.; Mostovaya, O.A.; Sevastyanov, D.A.; Lenina, O.A.; Sapunova, A.S.; Voloshina, A.D.; Petrov, K.A.; Kovyazina, I.V.; Cragg, P.J.; Stoikov, I.I. Supramolecular neuromuscular blocker inhibition by a pillar[5]arene through aqueous inclusion of rocuronium bromide. Org. Biomol. Chem. 2019, 17, 9951–9959. [Google Scholar] [CrossRef] [PubMed]
  25. Zhao, Q.; Zhu, J.; Chen, Y.; Dong, H.; Zhou, S.; Yin, Y.; Cai, Q.; Chen, S.; Chen, C.; Wang, L. Trapping and Reversing Neuromuscular Blocking Agent by Anionic Pillar[5]arenes: Understanding the Structure-Affinity-Reversal Effects. J. Hazard. Mater. 2024, 469, 133875. [Google Scholar] [CrossRef]
  26. Zhao, Y.; Chen, L.; Chen, J.; Li, J.; Meng, Q.; Sue, A.C.-H.; Li, C. Water-soluble terphen[3]arene macrocycle: A versatile reversal agent of neuromuscular blockers. Chem. Commun. 2023, 59, 5858–5861. [Google Scholar] [CrossRef] [PubMed]
  27. Selinger, A.J.; Cavallin, N.A.; Yanai, A.; Birol, I.; Hof, F. Template-Directed Synthesis of Bivalent, Broad-Spectrum Hosts for Neuromuscular Blocking Agents. Angew. Chem. 2022, 134, e202113235. [Google Scholar] [CrossRef]
  28. Pedersen, C.J. The Discovery of Crown Ethers (Noble Lecture). Angew. Chem. Int. Ed. Engl. 1988, 27, 1021–1027. [Google Scholar] [CrossRef]
  29. Lehn, J.-M. Supramolecular Chemistry—Scope and Perspectives Molecules, Supermolecules, and Molecular Devices (Nobel Lecture). Angew. Chem. Int. Ed. Engl. 1988, 27, 89–112. [Google Scholar] [CrossRef]
  30. Crini, G. Review: A History of Cyclodextrins. Chem. Rev. 2014, 114, 10940–10975. [Google Scholar] [CrossRef]
  31. Paolesse, R.; Nardis, S.; Monti, D.; Stefanelli, M.; Di Natale, C. Porphyrinoids for Chemical Sensor Applications. Chem. Rev. 2017, 117, 2517–2583. [Google Scholar] [CrossRef]
  32. Cheng, G.; Luo, J.; Liu, Y.; Chen, X.; Wu, Z.; Chen, T. Cucurbituril-Oriented Nanoplatforms in Biomedical Applications. ACS Appl. Bio Mater. 2020, 3, 8211–8824. [Google Scholar] [CrossRef] [PubMed]
  33. Kumar, R.; Sharma, A.; Singh, H.; Suating, P.; Kim, H.S.; Sunwoo, K.; Shim, I.; Gibb, B.C.; Kim, J.S. Revisiting Fluorescent Calixarenes: From Molecular Sensors to Smart Materials. Chem. Rev. 2019, 119, 9657–9721. [Google Scholar] [CrossRef]
  34. Lei, H.; Li, X.; Meng, J.; Zheng, H.; Zhang, W.; Cao, R. Structure Effects of Metal Corroles on Energy-Related Small Molecule Activation Reactions. ACS Catal. 2019, 9, 4320–4344. [Google Scholar] [CrossRef]
  35. Zyryanov, G.V.; Kopchuk, D.S.; Kovalev, I.S.; Santra, S.; Majee, A.; Ranu, B.C. Pillararenes as Promising Carriers for Drug Delivery. Int. J. Mol. Sci. 2023, 24, 5167. [Google Scholar] [CrossRef]
  36. Kralj, M.; Tušek-Božić, L.; Frkanec, L. Biomedical Potentials of Crown Ethers: Prospective Antitumor Agents. ChemMedChem 2008, 3, 1478–1492. [Google Scholar] [CrossRef]
  37. Chehardoli, G.; Bahmani, A. The role of crown ethers in drug delivery. Supramol. Chem. 2019, 31, 221–238. [Google Scholar] [CrossRef]
  38. Vatsadze, S.Z.; Maximov, A.L.; Bukhtiyarov, V.I. Supramolecular Effects and Systems in Catalysis. A Review. Dokl. Chem. 2022, 502, 1–27. [Google Scholar] [CrossRef]
  39. Gutsche, C.D. Calixarenes Revisited. Monographs in Supramolecular Chemistry; Stoddart, J.F., Ed.; The Royal Society of Chemistry: Cambridge, UK, 1998; 248p. [Google Scholar] [CrossRef]
  40. Morohashi, N.; Narumi, F.; Iki, N.; Hattori, T.; Miyano, S. Thiacalixarenes. Chem. Rev. 2006, 106, 5291–5316. [Google Scholar] [CrossRef]
  41. Jain, V.K.; Kanaiya, P.H. Chemistry of calix[4]resorcinarenes. Russ. Chem. Rev. 2011, 80, 75–102. [Google Scholar] [CrossRef]
  42. Ogoshi, T.; Yamagishi, T.; Nakamoto, Y. Pillar-Shaped Macrocyclic Hosts Pillar[n]arenes: New Key Players for Supramolecular Chemistry. Chem. Rev. 2016, 116, 7937–8002. [Google Scholar] [CrossRef] [PubMed]
  43. Fasting, C.; Schalley, C.A.; Weber, M.; Seitz, O.; Hecht, S.; Koksch, B.; Dernedde, J.; Graf, C.; Knapp, E.-W.; Haag, R. Multivalency as a chemical organization and action principle. Angew. Chem. Int. Ed. 2012, 51, 10472–10498. [Google Scholar] [CrossRef] [PubMed]
  44. Fa, S.; Kakuta, T.; Yamagishi, T.; Ogoshi, T. Conformation and Planar Chirality of Pillar[n]arenes. Chem. Lett. 2019, 48, 1278–1287. [Google Scholar] [CrossRef]
  45. Chen, J.-F.; Ding, J.-D.; Wei, T.-B. Pillararenes: Fascinating planar chiral macrocyclic arenes. Chem. Commun. 2021, 57, 9029–9039. [Google Scholar] [CrossRef]
  46. Barron, L.D. Chirality and Life. In Strategies of Life Detection; Botta, O., Bada, J.L., Gomez-Elvira, J., Javaux, E., Selsis, F., Summons, R., Eds.; Space Sciences Series of ISSI; Springer: Boston, MA, USA, 2008; Volume 25, pp. 187–201. [Google Scholar] [CrossRef]
  47. Blackmond, D.G. The origin of biological homochirality. Cold Spring Harb. Perspect. Biol. 2010, 2, a002147. [Google Scholar] [CrossRef]
  48. Uppuluri, S.; Swanson, D.R.; Piehler, L.T.; Li, J.; Hagnauer, G.L.; Tomalia, D.A. Core-Shell Tecto(dendrimers): I. Synthesis and Characterization of Saturated Shell Models. Adv. Mater. 2000, 12, 796–800. [Google Scholar] [CrossRef]
  49. Zhu, Y.; Gao, Y.; Rebek, J.; Yu, Y. Recent Applications of Pillararene-Inspired Water-Soluble Hosts. Chem. Eur. J. 2025, 31, e202404424. [Google Scholar] [CrossRef]
  50. Zhang, H.; Liu, Z.; Xin, F.; Zhao, Y. Metal-ligated pillararene materials: From chemosensors to multidimensional self-assembled architectures. Coord. Chem. Rev. 2020, 420, 213425. [Google Scholar] [CrossRef]
  51. Yan, M.; Zhou, J. Pillararene-Based Supramolecular Polymers for Cancer Therapy. Molecules 2023, 28, 1470. [Google Scholar] [CrossRef]
  52. Nierengarten, I.; Nothisen, M.; Sigwalt, D.; Biellmann, T.; Holler, M.; Remy, J.-S.; Nierengarten, J.-F. Polycationic Pillar[5]arene Derivatives: Interaction with DNA and Biological Applications. Chem. Eur. J. 2013, 19, 17552–17558. [Google Scholar] [CrossRef]
  53. Buffet, K.; Nierengarten, I.; Galanos, N.; Gillon, E.; Holler, M.; Imberty, A.; Matthews, S.E.; Vidal, S.; Vincent, S.P.; Nierengarten, J.-F. Pillar[5]arene-Based Glycoclusters: Synthesis and Multivalent Binding to Pathogenic Bacterial Lectins. Chem. Eur. J. 2016, 22, 2955–2963. [Google Scholar] [CrossRef] [PubMed]
  54. Stoikov, D.; Ivanov, A.; Shafigullina, I.; Gavrikova, M.; Padnya, P.; Shiabiev, I.; Stoikov, I.; Evtugyn, G. Flow-Through Amperometric Biosensor System Based on Functionalized Aryl Derivative of Phenothiazine and PAMAM-Calix-Dendrimers for the Determination of Uric Acid. Biosensors 2024, 14, 120. [Google Scholar] [CrossRef]
  55. Planells, M.; Abate, A.; Hollman, D.J.; Stranks, S.D.; Bharti, V.; Gaur, J.; Mohanty, D.; Chand, S.; Snaith, H.J.; Robertson, N. Diacetylene bridged triphenylamines as hole transport materials for solid state dye sensitized solar cells. J. Mater. Chem. A 2013, 1, 6949–6960. [Google Scholar] [CrossRef]
  56. Bettucci, O.; Pascual, J.; Turren-Cruz, S.-H.; Cabrera-Espinoza, A.; Matsuda, W.; Vӧlker, S.F.; Kӧbler, H.; Nierengarten, I.; Reginato, G.; Collavini, S.; et al. Dendritic-Like Molecules Built on a Pillar[5]arene Core as Hole Transporting Materials for Perovskite Solar Cells. Chem. Eur. J. 2021, 27, 8110–8117. [Google Scholar] [CrossRef] [PubMed]
  57. Timmerman, P.; Verboom, W.; Reinhoudt, D.N. Resorcinarenes. Tetrahedron 1996, 52, 2663–2704. [Google Scholar] [CrossRef]
  58. Tero, T.-R.; Nissinen, M. A perspective to resorcinarene crowns. Tetrahedron 2014, 70, 1111–1123. [Google Scholar] [CrossRef]
  59. Wang, K.; Liu, Q.; Zhou, L.; Sun, H.; Yao, X.; Hu, X.-Y. State-of-the-art and recent progress in resorcinarene-based cavitand. Chin. Chem. Lett. 2023, 34, 108559. [Google Scholar] [CrossRef]
  60. Wiegmann, S.; Fukuhara, G.; Neumann, B.; Stammler, H.-G.; Inoue, Y.; Mattay, J. Inherently Chiral Resorcin[4]arenes with Urea and Amide Side Arms: Synthesis, Structure and Chiral Recognition. Eur. J. Org. Chem. 2013, 2013, 1240–1245. [Google Scholar] [CrossRef]
  61. Castillo-Aguirre, A.A.; Sanabria-Español, E.; Maldonado, M.; Esteso, M.A. DMSO-controlled self-assembly of supramolecular structures of aryl-resorcinarenes. J. Mol. Liq. 2023, 387, 122703. [Google Scholar] [CrossRef]
  62. Li, M.; Soon Ho, C.K.; Wee On, I.K.; Gandon, V.; Zhu, Y. Inherently chiral resorcinarene cavitands through ionic catalyst-controlled cross-coupling. Chem 2024, 10, 3323–3341. [Google Scholar] [CrossRef]
  63. García Márquez, A.; Gutiérrez Nava, M.; Domínguez Chavez, J.G.; Klimova, E.; Klimova, T.; Martínez-Garcia, M. Supramolecular Complexes of Resorcinarene-Dendrimers and Fullerene C60. Fuller. Nanotub. Car. N. 2006, 14, 357–363. [Google Scholar] [CrossRef]
  64. Domínguez Chavez, J.G.; Gutiérrez Nava, M.; Flores Maturano, J.; Klimova, T.; Klimova, E.; Martínez-Garcia, M. Synthesis of Allyl-Bearing Dendrimers with a Resorcinarene Core and Their Supramolecular Complexes with Fullerene C60. J. Nanosci. Nanotechnol. 2007, 7, 1377–1385. [Google Scholar] [CrossRef]
  65. Lijanova, I.V.; Monter, R.G.; Likhanova, N.V.; Garibay, F.V.; Olivares, X.O.C. Synthesis of PAMAM dendrimers with a resorcinarene core and their metal complexation. Supramol. Chem. 2012, 24, 56–64. [Google Scholar] [CrossRef]
  66. Sandra, C.M.; Eduardo, C.C.; Simon, H.O.; Teresa, R.A.; Antonio, N.C.; Lijanova, I.V.; Marcos, M.G. Anticancer activity and anti-inflammatory studies of 5-aryl-1,4-benzodiazepine derivatives. Anticancer Agents Med. Chem. 2012, 12, 611–618. [Google Scholar] [CrossRef]
  67. Cortez-Maya, S.; Hernández-Ortega, S.; Ramírez-Apan, T.; Lijanova, I.V.; Martínez-García, M. Synthesis of 5-aryl-1,4-benzodiazepine derivatives attached in resorcinaren-PAMAM dendrimers and their anti-cancer activity. Bioorg. Med. Chem. 2012, 20, 415–421. [Google Scholar] [CrossRef] [PubMed]
  68. Bonelli, P.; Tuccillo, F.M.; Calemma, R.; Pezzetti, F.; Borrelli, A.; Martinelli, R.; De Rosa, A.; Esposito, D.; Palaia, R.; Castello, G. Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: A gene pathway analysis. Pharmacogenomics J. 2011, 11, 412–428. [Google Scholar] [CrossRef]
  69. Yao, M.; Zhou, W.; Sangha, S.; Albert, A.; Chang, A.J.; Liu, T.C.; Wolfe, M.M. Effects of Nonselective Cyclooxygenase Inhibition with Low-Dose Ibuprofen on Tumor Growth, Angiogenesis, Metastasis, and Survival in a Mouse Model of Colorectal Cancer. Clin. Cancer Res. 2005, 11, 1618–1628. [Google Scholar] [CrossRef] [PubMed]
  70. Pedro-Hernández, L.D.; Martínez-Klimova, E.; Cortez-Maya, S.; Mendoza-Cardozo, S.; Ramírez-Ápan, T.; Martínez-García, M. Synthesis, Characterization, and Nanomedical Applications of Conjugates between Resorcinarene-Dendrimers and Ibuprofen. Nanomaterials 2017, 7, 163. [Google Scholar] [CrossRef]
  71. Mendoza-Cardozo, S.; Pedro-Hernández, L.D.; Organista-Mateos, U.; Allende-Alarcón, L.I.; Martínez-Klimova, E.; Ramírez-Ápan, T.; Martínez-García, M. In vitro activity of resorcinarene-chlorambucil conjugates for therapy in human chronic myelogenous leukemia cells. Drug Dev. Ind. Pharm. 2019, 45, 683–688. [Google Scholar] [CrossRef] [PubMed]
  72. Cortez-Maya, S.; Klimova, E.; Puente Lee, R.I.; Borja-Miranda, A.; Martínez-García, M. Synthesis and Characterization of Ferrocenyl Carboxilic Surface-Functionalized Resorcinaren-PAMAM Dendrimers. Curr. Org. Chem. 2015, 19, 1954–1960. [Google Scholar] [CrossRef]
  73. Pedro-Hernández, L.D.; Martínez-Klimova, E.; Martínez-Klimov, M.E.; Cortez-Maya, S.; Vargas-Medina, A.C.; Ramírez-Ápan, T.; Hernández-Ortega, S.; Martínez-García, M. Anticancer Activity of Resorcinarene-PAMAM-Dendrimer Conjugates of Flutamide. Anti-Cancer Agents Med. Chem. 2018, 18, 993–1000. [Google Scholar] [CrossRef]
  74. Knyazeva, I.R.; Syakaev, V.V.; Habicher, W.D.; Burilov, A.R. Novel first-generation dendrimers on calix[4]resorcinol core equipped with multiple triazole units. Mendeleev Commun. 2022, 32, 103–104. [Google Scholar] [CrossRef]
  75. Cheriaa, N.; Mahouachi, M.; Othman, A.B.; Baklouti, L.; Abidi, R.; Kim, J.S.; Kim, Y.; Harrowfield, J.; Vicens, J. Calixdendrimers. In Calixarenes in the Nanoworld; Vicens, J., Harrowfield, J., Eds.; Springer: Dordrecht, The Netherlands, 2007; pp. 89–108. [Google Scholar]
  76. Lhoták, P.; Shinkai, S. Synthesis and metal-binding properties of oligo-calixarenes. An approach towards the calix[4]arene-based dendrimers. Tetrahedron 1995, 51, 7681–7696. [Google Scholar] [CrossRef]
  77. Štatastný, V.; Stibor, I.; Dvořáková, H.; Lhoták, P. Synthesis of (thia)calix[4]arene oligomers: Towards calixarene-based dendrimers. Tetrahedron 2004, 60, 3383–3391. [Google Scholar] [CrossRef]
  78. Xu, H.; Kinsel, G.R.; Zhang, J.; Li, M.; Rudkevich, D.M. Calixarene amino acids; building blocks for calixarene peptides and peptide-dendrimers. Tetrahedron 2003, 59, 5837–5848. [Google Scholar] [CrossRef]
  79. Mahouachi, M.; Kim, Y.; Lee, S.H.; Abidi, R.; Harrowfield, J.; Vicens, J. Calixarene-based Hyperbranched Molecules with an N,S-Multidentate Ligand Core. Supramol. Chem. 2005, 14, 323–330. [Google Scholar] [CrossRef]
  80. Kellermann, M.; Bauer, W.; Hirsch, A.; Schade, B.; Ludwig, K.; Bӧttcher, C. The First Account of a Structurally Persistent Micelle. Angew. Chem. Int. Ed. 2004, 43, 2959–2962. [Google Scholar] [CrossRef] [PubMed]
  81. Appelhans, D.; Smet, M.; Khimich, G.; Komber, H.; Voigt, D.; Lhoták, P.; Kucklinge, D.; Voit, B. Lysine dendrimers based on thiacalix[4]arene core moieties as molecular scaffolds for supramolecular host systems. New J. Chem. 2005, 29, 1386–1389. [Google Scholar] [CrossRef]
  82. Zhang, F.; Sun, Y.; Tian, D.; Shin, W.S.; Kim, J.S.; Li, H. Selective molecular recognition on calixarene-functionalized 3D surfaces. Chem. Commun. 2016, 52, 12685–12693. [Google Scholar] [CrossRef]
  83. Shiabiev, I.; Pysin, D.; Kharlamova, A.; Zueva, I.; Petrov, K.; Bukharov, M.; Babaeva, O.; Mostovaya, O.; Padnya, P.; Stoikov, I. Design of reversible cholinesterase inhibitors: Fine-tuning of enzymatic activity by PAMAM-calix-dendrimers. Int. J. Biol. Macromol. 2025, 287, 138503. [Google Scholar] [CrossRef]
  84. Terenteva, O.; Mostovaya, O.; Bukharov, M.; Mykhametzyanov, T.; Bikmukhametov, A.; Lyubina, A.; Voloshina, A.; Petrov, K.; Padnya, P.; Stoikov, I. Peptidomimetics based on thiacalixarene with L-tyrosine moieties: Antibacterial activity against methicillin-resistant Staphylococcus aureus and degradation induced by binding to α-chymotrypsin. Bioorg. Chem. 2025, 160, 108434. [Google Scholar] [CrossRef]
  85. Mostovaya, O.; Shiabiev, I.; Pysin, D.; Stanavaya, A.; Abashkin, V.; Shcharbin, D.; Padnya, P.; Stoikov, I. PAMAM-Calix-Dendrimers: Second Generation Synthesis, Fluorescent Properties and Catecholamines Binding. Pharmaceutics 2022, 14, 2748. [Google Scholar] [CrossRef]
  86. Mostovaya, O.A.; Padnya, P.L.; Shurpik, D.N.; Shiabiev, I.E.; Stoikov, I.I. Novel lactide derivatives of p-tert-butylthiacalix[4]arene: Directed synthesis and molecular recognition of catecholamines. J. Mol. Liq. 2021, 327, 114806. [Google Scholar] [CrossRef]
  87. Mostovaya, O.; Shiabiev, I.; Ovchinnikov, D.; Pysin, D.; Mukhametzyanov, T.; Stanavaya, A.; Abashkin, V.; Shcharbin, D.; Khannanov, A.; Kutyreva, M.; et al. PAMAM-Calix-Dendrimers: Third Generation Synthesis and Impact of Generation and Macrocyclic Core Conformation on Hemotoxicity and Calf Thymus DNA Binding. Pharmaceutics 2024, 16, 1379. [Google Scholar] [CrossRef]
  88. Fischer, D.; Li, Y.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T. In Vitro Cytotoxicity Testing of Polycations: Influence of Polymer Structure on Cell Viability and Hemolysis. Biomaterials 2003, 24, 1121–1131. [Google Scholar] [CrossRef]
  89. Dománski, D.M.; Klajnert, B.; Bryszewska, M. Influence of PAMAM Dendrimers on Human Red Blood Cells. Bioelectrochemistry 2004, 63, 189–191. [Google Scholar] [CrossRef]
  90. Mostovaya, O.; Padnya, P.; Shiabiev, I.; Mukhametzyanov, T.; Stoikov, I. PAMAM-calix-dendrimers: Synthesis and Thiacalixarene Conformation Effect on DNA Binding. Int. J. Mol. Sci. 2021, 22, 11901. [Google Scholar] [CrossRef]
  91. Khairutdinov, B.; Ermakova, E.; Sitnitsky, A.; Stoikov, I.; Zuev, Y. Supramolecular complex formed by DNA oligonucleotide and thiacalix[4]arene. NMR-spectroscopy and molecular docking. J. Mol. Struct. 2014, 1074, 126–133. [Google Scholar] [CrossRef]
  92. Yakimova, L.S.; Puplampu, J.B.; Evtugin, G.A.; Stoikov, I.I. Polyfunctional branched nitrogen-containing p-tert-butylthiacalix[4]arene derivatives as efficient agents for packaging calf thymus DNA. Russ. Chem. Bull. 2017, 66, 1515–1523. [Google Scholar] [CrossRef]
  93. Padnya, P.; Shiabiev, I.; Pysin, D.; Gerasimova, T.; Ranishenka, B.; Stanavaya, A.; Abashkin, V.; Shcharbin, D.; Shi, X.; Shen, M.; et al. Non-Viral Systems Based on PAMAM-Calix-Dendrimers for Regulatory siRNA Delivery into Cancer Cells. Int. J. Mol. Sci. 2024, 25, 12614. [Google Scholar] [CrossRef] [PubMed]
  94. Zare, M.; Pemmada, R.; Madhavan, M.; Shailaja, A.; Ramakrishna, S.; Kandiyil, S.P.; Donahue, J.M.; Thomas, V. Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics. Pharmaceutics 2022, 14, 1620. [Google Scholar] [CrossRef]
  95. Kulikova, T.; Padnya, P.; Shiabiev, I.; Rogov, A.; Stoikov, I.; Evtugyn, G. Electrochemical Sensing of Interactions between DNA and Charged Macrocycles. Chemosensors 2021, 9, 347. [Google Scholar] [CrossRef]
  96. Kulikova, T.; Shamagsumova, R.; Rogov, A.; Stoikov, I.; Padnya, P.; Shiabiev, I.; Evtugyn, G. Electrochemical DNA-Sensor Based on Macrocyclic Dendrimers with Terminal Amino Groups and Carbon Nanomaterials. Sensors 2023, 23, 4761. [Google Scholar] [CrossRef]
  97. Padnya, P.; Mostovaya, O.; Ovchinnikov, D.; Shiabiev, I.; Pysin, D.; Akhmedov, A.; Mukhametzyanov, T.; Lyubina, A.; Voloshina, A.; Petrov, K.; et al. Combined antimicrobial agents based on self-assembled PAMAM-calix-dendrimers/lysozyme nanoparticles: Design, antibacterial properties and cytotoxicity. J. Mol. Liq. 2023, 389, 122838. [Google Scholar] [CrossRef]
  98. Rosales-Hurtado, M.; Meffre, P.; Szurmant, H.; Benfodda, Z. Synthesis of histidine kinase inhibitors and their biological properties. Med. Res. Rev. 2020, 40, 1440–1495. [Google Scholar] [CrossRef]
  99. Alenazi, N.A.; Aleanizy, F.S.; Alqahtani, F.Y.; Aldossari, A.A.; Alanazi, M.M.; Alfaraj, R. Anti-quorum sensing activity of poly-amidoamine dendrimer generation 5 dendrimer loaded kinase inhibitor peptide against methicillin-resistant Staphylococcus aureus. Saudi Pharm. J. 2024, 32, 101932. [Google Scholar] [CrossRef]
  100. Nazarova, A.; Shiabiev, I.; Shibaeva, K.; Mostovaya, O.; Mukhametzyanov, T.; Khannanov, A.; Evtugyn, V.; Zelenikhin, P.; Shi, X.; Shen, M.; et al. Thiacalixarene Carboxylic Acid Derivatives as Inhibitors of Lysozyme Fibrillation. Int. J. Mol. Sci. 2024, 25, 4721. [Google Scholar] [CrossRef]
  101. Martinez, A.; Castro, A. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease. Expert Opin. Investig. Drugs 2006, 15, 1–12. [Google Scholar] [CrossRef]
  102. Mantegazza, R.; Bonanno, S.; Camera, G.; Antozzi, C. Current and emerging therapies for the treatment of myasthenia gravis. Neuropsychiatr. Dis. Treat. 2011, 7, 151–160. [Google Scholar] [CrossRef] [PubMed]
  103. Shurpik, D.N.; Padnya, P.L.; Stoikov, I.I.; Cragg, P.J. Antimicrobial Activity of Calixarenes and Related Macrocycles. Molecules 2020, 25, 5145. [Google Scholar] [CrossRef] [PubMed]
  104. Shiabiev, I.E.; Pysin, D.A.; Akhmedov, A.A.; Babaeva, O.B.; Babaev, V.M.; Lyubina, A.P.; Voloshina, A.D.; Petrov, K.A.; Padnya, P.L.; Stoikov, I.I. Towards antibacterial agents: Synthesis and biological activity of multivalent amide derivatives of thiacalix[4]arene with hydroxyl and amine groups. Pharmaceutics 2023, 15, 2731. [Google Scholar] [CrossRef]
  105. Shiabiev, I.E.; Pysin, D.A.; Padnya, P.L.; Stoikov, I.I. First-Generation Dendrimers Based on Thiacalix[4]arene Containing Hydroxyl Terminal Groups: Synthesis and Self-Assembly. Russ. J. Gen. Chem. 2022, 92, 2574–2581. [Google Scholar] [CrossRef]
  106. Mostovaya, O.A.; Vavilova, A.A.; Stoikov, I.I. Supramolecular Systems Based on Thiacalixarene Derivatives and Biopolymers. Colloid J. 2022, 84, 546–562. [Google Scholar] [CrossRef]
  107. Kamaly, N.; He, J.C.; Ausiello, D.A.; Farokhzad, N.K.O.C. Nanomedicines for renal disease: Current status and future applications. Nat. Rev. Nephrol. 2016, 12, 738–753. [Google Scholar] [CrossRef]
  108. Hao, M.; Chen, B.; Zhao, X.; Zhao, N.; Xu, F.-J. Organic/inorganic nanocomposites for cancer immunotherapy. Mater. Chem. Front. 2020, 4, 2571–2609. [Google Scholar] [CrossRef]
  109. Esfand, R.; Tomalia, D.A. Poly(amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications. Drug Discov. Today 2001, 8, 117–236. [Google Scholar] [CrossRef]
  110. Stoikov, I.I.; Galukhin, A.V.; Zaikov, E.N.; Antipin, I.S. Synthesis and complexation properties of 1,3-alternate stereoisomers of p-tert-butylthiacalix[4]arenes tetrasubstituted at the lower rim by the phthalimide group. Mendeleev Commun. 2009, 19, 193–195. [Google Scholar] [CrossRef]
  111. Fayzullin, D.A.; Vylegzhanina, N.N.; Gnezdilov, O.I.; Salnikov, V.V.; Galukhin, A.V.; Stoikov, I.I.; Antipin, I.S.; Zuev, Y.F. Influence of Nature of Functional Groups on Interaction of Tetrasubstituted at Lower Rim p-tert-Butyl Thiacalix[4]arenes in 1,3-Alternate Configuration with Model Lipid Membranes. Appl. Magn. Reson. 2011, 40, 231–243. [Google Scholar] [CrossRef]
  112. Shibaeva, K.S.; Nazarova, A.A.; Kuznetsova, D.I.; Stoikov, I.I. Synthesis of aminobismethylenephosphonic acids on a platform of p-tert-Butylthiacalix[4]arene in 1,3-alternate configuration. Rus. J. Gen. Chem. 2016, 86, 579–583. [Google Scholar] [CrossRef]
  113. Yakimova, L.; Vavilova, A.; Shibaeva, K.; Sultanaev, V.; Mukhametzyanov, T.; Stoikov, I. Supramolecular approaches to the formation of nanostructures based on phosphonate-thiacalix[4]arenes, their selective lysozyme recognition. Colloids Surf. A Physicochem. Eng. Asp. 2021, 611, 125897. [Google Scholar] [CrossRef]
  114. Yakimova, L.S.; Sultanaev, V.R.; Vavilova, A.A.; Shibaeva, K.S.; Stoikov, I.I. Self-assembly of interpolyelectrolyte complexes and mixed micelles from guanidinium and phosphonate derivatives of p-tert-butylthiacalix[4]arene and solubilization of paclitaxel. J. Mol. Liq. 2024, 395, 123836. [Google Scholar] [CrossRef]
  115. Olenyuk, B.; Leininger, S.; Stang, P.J. Self-assembly of discrete cyclic nanostructures mediated by transition metals. Chem. Rev. 2000, 100, 853–907. [Google Scholar] [CrossRef]
  116. Št’astný, V.; Stibor, I.; Petříčková, H.; Sýkora, J.; Lhoták, P. Thiacalix[4]arene derivatives with proximally bridged lower rim. Tetrahedron 2005, 61, 9990–9995. [Google Scholar] [CrossRef]
  117. Fatykhova, A.M.; Sultanova, E.D.; Burilov, V.A.; Gafiatullin, B.K.; Fedoseeva, A.A.; Veshta, T.A.; Ziganshin, M.A.; Ziganshina, S.A.; Evtugyn, V.G.; Islamov, D.R.; et al. Gallic acid-based dendrimers with thiacalix[4]arene core: Synthesis, aggregation and use for Pd NP’s stabilization. New J. Chem. 2023, 47, 19223–19234. [Google Scholar] [CrossRef]
  118. Sultanova, E.D.; Fedoseeva, A.A.; Fatykhova, A.M.; Mironova, D.A.; Ziganshina, S.A.; Ziganshin, M.A.; Evtugyn, V.G.; Burilov, V.A.; Solovieva, S.E.; Antipin, I.S. Multi-functional imidazolium dendrimers based on thiacalix[4]arenes: Self-assembly, catalysis and DNA binding. Soft Matter 2024, 20, 7072–7082. [Google Scholar] [CrossRef]
  119. Ocherednyuk, E.A.; Sultanova, E.D.; Makarov, E.G.; Fedoseeva, A.A.; Khannanov, A.A.; Evtugyn, V.G.; Solovieva, S.E.; Burilov, V.A.; Antipin, I.S. Epichlorohydrin-based CuAAC dendrimers with a calix[4]arene core and polar hydroxyl/oxyethyl terminal groups: Synthesis, aggregation and use in catalysis. New J. Chem. 2024, 48, 13999–14012. [Google Scholar] [CrossRef]
  120. Burilov, V.; Makarov, E.; Mironova, D.; Sultanova, E.; Bilyukova, I.; Akyol, K.; Evtugyn, V.; Islamov, D.; Usachev, K.; Mukhametzyanov, T.; et al. Calix[4]arene Polyamine Triazoles: Synthesis, Aggregation and DNA Binding. Int. J. Mol. Sci. 2022, 23, 14889. [Google Scholar] [CrossRef]
  121. Burilov, V.A.; Fatikhova, G.A.; Dokuchaeva, M.N.; Nugmanov, R.I.; Mironova, D.A.; Dorovatovskii, P.V.; Khrustalev, V.N.; Solovieva, S.E.; Antipin, I.S. Synthesis of new p-tert-butylcalix[4]arene-based polyammonium triazolyl amphiphiles and their binding with nucleoside phosphates. Beilstein J. Org. Chem. 2018, 14, 1980–1993. [Google Scholar] [CrossRef]
  122. Marradi, M.; Cicchi, S.; Sansone, F.; Casnati, A.; Goti, A. Low-generation dendrimers with a calixarene core and based on a chiral C2-symmetric pyrrolidine as iminosugar mimics. Beilstein J. Org. Chem. 2012, 8, 951–957. [Google Scholar] [CrossRef] [PubMed]
  123. Kumar, S.; Yadav, M.S.; Singh, S.K.; Rajkhowa, S.; Tiwari, V.K. Synthesis of Calix[4]arene Appended Lactosylated G1 and Galactosylated G2 Generation Glycodendrimers using a ‘CuAAC’ Click Approach. SynOpen 2023, 7, 145–153. [Google Scholar] [CrossRef]
  124. Rahimi, M.; Karimian, R.; Mostafidi, E.; Noruzi, E.B.; Taghizadeh, S.; Shokouhi, B.; Kafil, H.S. Highly branched amine-functionalized p-sulfonatocalix[4]arene decorated with human plasma proteins as a smart, targeted, and stealthy nano-vehicle for the combination chemotherapy of MCF7 cells. New J. Chem. 2018, 42, 13010–13024. [Google Scholar] [CrossRef]
  125. Kritika; Roy, I. Therapeutic applications of magnetic nanoparticles: Recent advances. Mater. Adv. 2022, 3, 7425–7444. [Google Scholar] [CrossRef]
  126. Rudzevich, Y.; Fischer, K.; Schmidt, M.; Bӧhmer, V. Fourfold tetraurea calix[4]arenes—Potential cores for the formation of self-assembled dendrimers. Org. Biomol. Chem. 2005, 3, 3916–3925. [Google Scholar] [CrossRef] [PubMed]
  127. Rudzevich, Y.; Rudzevich, V.; Moon, C.; Schnell, I.; Fischer, K.; Bӧhmer, V. Self-Assembly of Programmed Building Blocks into Structurally Uniform Dendrimers. J. Am. Chem. Soc. 2005, 127, 14168–14169. [Google Scholar] [CrossRef] [PubMed]
  128. Bu, J.-H.; Zheng, Q.-Y.; Chen, C.-F.; Huang, Z.-T. The synthesis of calix[4]crown based dendrimer. Tetrahedron 2005, 61, 897–902. [Google Scholar] [CrossRef]
  129. Shurpik, D.N.; Yakimova, L.S.; Gorbachuk, V.V.; Sevastyanov, D.A.; Padnya, P.L.; Bazanova, O.B.; Rizvanov, I.K.; Stoikov, I.I. Hybrid multicyclophanes based on thiacalix[4]arene and pillar[5]arene: Synthesis and influence on the formation of polyaniline. Org. Chem. Front. 2018, 5, 2780–2786. [Google Scholar] [CrossRef]
  130. Khadieva, A.; Gorbachuk, V.; Shurpik, D.; Stoikov, I. Synthesis of Tris-pillar[5]arene and Its Association with Phenothiazine Dye: Colorimetric Recognition of Anions. Molecules 2019, 24, 1807. [Google Scholar] [CrossRef]
  131. Elizarov, A.M.; Chang, T.; Chiu, S.-H.; Stoddart, J.F. Self-Assembly of Dendrimers by Slippage. Org. Lett. 2002, 4, 3565–3568. [Google Scholar] [CrossRef]
  132. Liu, G.; Li, Z.; Wu, D.; Xue, W.; Li, T.; Liu, S.H.; Yin, J. Dendritic[2]Rotaxanes: Synthesis, Characterization, and Properties. J. Org. Chem. 2014, 79, 643–652. [Google Scholar] [CrossRef]
  133. Newkome, G.R.; Kim, H.J.; Choi, K.H.; Moorefield, C.N. Synthesis of Neutral Metallodendrimers Possessing Adamantane Termini: Supramolecular Assembly with β-Cyclodextrin. Macromolecules 2004, 37, 6268–6274. [Google Scholar] [CrossRef]
  134. Schönbeck, C.; Li, H.; Han, B.-H.; Laursen, B.W. Solvent Effects and Driving Forces in Pillararene Inclusion Complexes. J. Phys. Chem. B 2015, 119, 6711–6720. [Google Scholar] [CrossRef]
  135. Chi, X.; Xue, M. Inclusion[2]complexes based on a pillar[5]arene with mono(ethylene oxide) substituents and vinylogous viologens. RSC Adv. 2014, 4, 365–368. [Google Scholar] [CrossRef]
  136. Li, Q.; Han, K.; Li, J.; Jia, X.; Li, C. Synthesis of dendrimer-functionalized pillar[5]arenes and their self-assembly to dimeric and trimeric complexes. Tetrahedron Lett. 2015, 56, 3826–3829. [Google Scholar] [CrossRef]
  137. Li, C.; Han, K.; Li, J.; Zhang, Y.; Chen, W.; Yu, Y.; Jia, X. Supramolecular Polymers Based on Efficient Pillar[5]arene—Neutral Guest Motifs. Chem. Eur. J. 2013, 19, 11892–11897. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The structures of cyclophane macrocycles.
Figure 1. The structures of cyclophane macrocycles.
Molecules 30 04211 g001
Scheme 1. Reagents and conditions: (i) R-N3, CuSO4·5H2O, sodium ascorbate, CH2Cl2/H2O (2: 88%, 3: 81%); (ii) TFA (4: quantitative, 5: quantitative).
Scheme 1. Reagents and conditions: (i) R-N3, CuSO4·5H2O, sodium ascorbate, CH2Cl2/H2O (2: 88%, 3: 81%); (ii) TFA (4: quantitative, 5: quantitative).
Molecules 30 04211 sch001
Scheme 2. Synthesis of the first- and second-generation dendrimers with terminal sugar residues. Reagents and conditions: (a) CuI, iPr2NEt, DMF, 110 °C, 15 min microwaves, 77% (compound 7), 71% (compound 8); (b) MeOH, MeONa, room temperature, 84% (compound 9), 72% (compound 10). Reprinted with permission from Ref. [53]. Copyright 2016 Wiley-VCH GmbH, Weinheim.
Scheme 2. Synthesis of the first- and second-generation dendrimers with terminal sugar residues. Reagents and conditions: (a) CuI, iPr2NEt, DMF, 110 °C, 15 min microwaves, 77% (compound 7), 71% (compound 8); (b) MeOH, MeONa, room temperature, 84% (compound 9), 72% (compound 10). Reprinted with permission from Ref. [53]. Copyright 2016 Wiley-VCH GmbH, Weinheim.
Molecules 30 04211 sch002
Figure 2. Structure of the dendrimer-like pillar[5]arene derivatives 11 and 12.
Figure 2. Structure of the dendrimer-like pillar[5]arene derivatives 11 and 12.
Molecules 30 04211 g002
Figure 3. First–third generation dendrimers with terminal allyl fragments 1315 and an example of the complex with fullerene 13/C60.
Figure 3. First–third generation dendrimers with terminal allyl fragments 1315 and an example of the complex with fullerene 13/C60.
Molecules 30 04211 g003
Scheme 3. Divergent synthesis of the first-generation dendrimers based on resorcinarene.
Scheme 3. Divergent synthesis of the first-generation dendrimers based on resorcinarene.
Molecules 30 04211 sch003
Scheme 4. Synthesis of the second-generation dendrimers based on resorcinarene.
Scheme 4. Synthesis of the second-generation dendrimers based on resorcinarene.
Molecules 30 04211 sch004
Scheme 5. Functionalization of the resorcinarene-based dendrimers with 5-aryl-1,4-benzodiazepine moieties.
Scheme 5. Functionalization of the resorcinarene-based dendrimers with 5-aryl-1,4-benzodiazepine moieties.
Molecules 30 04211 sch005
Figure 4. The first and second generations of dendrimers with terminal ibuprofen fragments. Reprinted with permission from Ref. [70]. Copyright 2017 MDPI.
Figure 4. The first and second generations of dendrimers with terminal ibuprofen fragments. Reprinted with permission from Ref. [70]. Copyright 2017 MDPI.
Molecules 30 04211 g004
Figure 5. First- and second-generation dendrimers with terminal chorambucil fragments.
Figure 5. First- and second-generation dendrimers with terminal chorambucil fragments.
Molecules 30 04211 g005
Scheme 6. Diethylenetriamine used for resorcinarene-based dendrimer branching.
Scheme 6. Diethylenetriamine used for resorcinarene-based dendrimer branching.
Molecules 30 04211 sch006
Scheme 7. Synthesis of metallodendrimers based on resorcinarene and ferrocene carboxylic acid.
Scheme 7. Synthesis of metallodendrimers based on resorcinarene and ferrocene carboxylic acid.
Molecules 30 04211 sch007
Scheme 8. Conjugation of the resorcinarene-based dendrimers with flutamide.
Scheme 8. Conjugation of the resorcinarene-based dendrimers with flutamide.
Molecules 30 04211 sch008
Scheme 9. Synthesis of the dendrimers based on resorcinarenes with dendron fragments at bridging methylene groups.
Scheme 9. Synthesis of the dendrimers based on resorcinarenes with dendron fragments at bridging methylene groups.
Molecules 30 04211 sch009
Figure 6. Dendrimers based on different stereoisomers of thiacalix[4]arene of first, second and third generations. Reprinted with permission from Ref. [85]. Copyright 2022 MDPI.
Figure 6. Dendrimers based on different stereoisomers of thiacalix[4]arene of first, second and third generations. Reprinted with permission from Ref. [85]. Copyright 2022 MDPI.
Molecules 30 04211 g006
Figure 7. Charge distribution in PAMAM-calix-dendrimers relative to the macrocyclic platform. Reprinted with permission from Ref. [87]. Copyright 2024 MDPI.
Figure 7. Charge distribution in PAMAM-calix-dendrimers relative to the macrocyclic platform. Reprinted with permission from Ref. [87]. Copyright 2024 MDPI.
Molecules 30 04211 g007
Figure 8. Dendronized derivatives of p-tert-butylthiacalix[4]arene 72 and 73.
Figure 8. Dendronized derivatives of p-tert-butylthiacalix[4]arene 72 and 73.
Molecules 30 04211 g008
Figure 9. Schematic representation of the operating principle of electrochemical DNA sensors based on dendronized thiacalixarenes for doxorubicin determination. Reprinted with permission from Ref. [96]. Copyright 2023 MDPI.
Figure 9. Schematic representation of the operating principle of electrochemical DNA sensors based on dendronized thiacalixarenes for doxorubicin determination. Reprinted with permission from Ref. [96]. Copyright 2023 MDPI.
Molecules 30 04211 g009
Figure 10. Schematic representation of different charge formations at the surface of electrochemical DNA sensors based on dendronized thiacalixarenes. Reprinted with permission from Ref. [96]. Copyright 2023 MDPI.
Figure 10. Schematic representation of different charge formations at the surface of electrochemical DNA sensors based on dendronized thiacalixarenes. Reprinted with permission from Ref. [96]. Copyright 2023 MDPI.
Molecules 30 04211 g010
Figure 11. Dendronized thiacalixarene 74.
Figure 11. Dendronized thiacalixarene 74.
Molecules 30 04211 g011
Figure 12. Components of the electrochemical biosensor for the determination of uric acid. Reprinted with permission from Ref. [54]. Copyright 2024 MDPI.
Figure 12. Components of the electrochemical biosensor for the determination of uric acid. Reprinted with permission from Ref. [54]. Copyright 2024 MDPI.
Molecules 30 04211 g012
Figure 13. Calix-dendrimers with terminal carboxylate fragments capable of inhibiting lysozyme fibrillation. Reprinted with permission from Ref. [100]. Copyright 2024 MDPI.
Figure 13. Calix-dendrimers with terminal carboxylate fragments capable of inhibiting lysozyme fibrillation. Reprinted with permission from Ref. [100]. Copyright 2024 MDPI.
Molecules 30 04211 g013
Figure 14. PAMAM-calix-dendrimers capable of inhibiting cholinesterase.
Figure 14. PAMAM-calix-dendrimers capable of inhibiting cholinesterase.
Molecules 30 04211 g014
Figure 15. Illustration of the mechanism of calix-dendrimer different conformations’ effect on a model lipid membrane. Reprinted with permission from Ref. [104]. Copyright 2023 MDPI.
Figure 15. Illustration of the mechanism of calix-dendrimer different conformations’ effect on a model lipid membrane. Reprinted with permission from Ref. [104]. Copyright 2023 MDPI.
Molecules 30 04211 g015
Figure 16. First-generation calix-dendrimer with terminal amino diacetate fragments.
Figure 16. First-generation calix-dendrimer with terminal amino diacetate fragments.
Molecules 30 04211 g016
Scheme 10. Synthesis of first- and second-generation phosphorylated calix-dendrimers by the Moedritzer–Irani method.
Scheme 10. Synthesis of first- and second-generation phosphorylated calix-dendrimers by the Moedritzer–Irani method.
Molecules 30 04211 sch010
Figure 17. Creation of intermolecular associates based on macrocyclic compounds.
Figure 17. Creation of intermolecular associates based on macrocyclic compounds.
Molecules 30 04211 g017
Scheme 11. Divergent synthesis of third-generation PAMAM-calix-dendrimers. Reprinted with permission from Ref. [87]. Copyright 2024 MDPI.
Scheme 11. Divergent synthesis of third-generation PAMAM-calix-dendrimers. Reprinted with permission from Ref. [87]. Copyright 2024 MDPI.
Molecules 30 04211 sch011
Scheme 12. Convergent synthesis of first-generation calix-dendrimers via Cu-catalyzed alkyne-azide cycloaddition reaction.
Scheme 12. Convergent synthesis of first-generation calix-dendrimers via Cu-catalyzed alkyne-azide cycloaddition reaction.
Molecules 30 04211 sch012
Scheme 13. Synthesis of first-generation calix-dendrimers with terminal imidazolium groups.
Scheme 13. Synthesis of first-generation calix-dendrimers with terminal imidazolium groups.
Molecules 30 04211 sch013
Scheme 14. Synthesis of first-generation calix-dendrimers with terminal imidazolium groups.
Scheme 14. Synthesis of first-generation calix-dendrimers with terminal imidazolium groups.
Molecules 30 04211 sch014
Scheme 15. Dendronization of the upper rim of thiacalixarenes.
Scheme 15. Dendronization of the upper rim of thiacalixarenes.
Molecules 30 04211 sch015
Figure 18. Polyammonium compound 127.
Figure 18. Polyammonium compound 127.
Molecules 30 04211 g018
Scheme 16. Synthesis of calixarene-based dendrimers 129 and 131. Reagents and conditions: DIPEA, CH2Cl2, 30 °C, 5 d, (Su: succinimidyl; TBDMS: tert-butyldimethylsilyl).
Scheme 16. Synthesis of calixarene-based dendrimers 129 and 131. Reagents and conditions: DIPEA, CH2Cl2, 30 °C, 5 d, (Su: succinimidyl; TBDMS: tert-butyldimethylsilyl).
Molecules 30 04211 sch016
Scheme 17. Synthesis of calix[4]arene-appended lactosylated G1 generation glycodendrimer 134 and galactosylated G2 generation glycodendrimer 136.
Scheme 17. Synthesis of calix[4]arene-appended lactosylated G1 generation glycodendrimer 134 and galactosylated G2 generation glycodendrimer 136.
Molecules 30 04211 sch017
Scheme 18. Grafting amine functional groups onto the surface of p-sulfonatocalix[4]arene, and preparation of calix-dendrimer 139 via performing the Michael addition and amidation reactions.
Scheme 18. Grafting amine functional groups onto the surface of p-sulfonatocalix[4]arene, and preparation of calix-dendrimer 139 via performing the Michael addition and amidation reactions.
Molecules 30 04211 sch018
Figure 19. Two synthetic paths for hybrid multicyclophane preparation.
Figure 19. Two synthetic paths for hybrid multicyclophane preparation.
Molecules 30 04211 g019
Scheme 19. Synthesis of hybrid multicyclophanes 143 and 144.
Scheme 19. Synthesis of hybrid multicyclophanes 143 and 144.
Molecules 30 04211 sch019
Scheme 20. Synthesis of tris-pillar[5]arene 146.
Scheme 20. Synthesis of tris-pillar[5]arene 146.
Molecules 30 04211 sch020
Scheme 21. Synthesis of monosubstituted dendronized pillararenes and the structures of hosts and connectors.
Scheme 21. Synthesis of monosubstituted dendronized pillararenes and the structures of hosts and connectors.
Molecules 30 04211 sch021
Figure 20. Schematic illustration of supramolecular trimeric dendrimer formation and its disassembly after adding a competitive guest.
Figure 20. Schematic illustration of supramolecular trimeric dendrimer formation and its disassembly after adding a competitive guest.
Molecules 30 04211 g020
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mostovaya, O.; Vavilova, A.; Gazizova, A.; Stoikov, I. Cyclophane-Based Dendrimers: Today and Tomorrow. Molecules 2025, 30, 4211. https://doi.org/10.3390/molecules30214211

AMA Style

Mostovaya O, Vavilova A, Gazizova A, Stoikov I. Cyclophane-Based Dendrimers: Today and Tomorrow. Molecules. 2025; 30(21):4211. https://doi.org/10.3390/molecules30214211

Chicago/Turabian Style

Mostovaya, Olga, Alena Vavilova, Asiya Gazizova, and Ivan Stoikov. 2025. "Cyclophane-Based Dendrimers: Today and Tomorrow" Molecules 30, no. 21: 4211. https://doi.org/10.3390/molecules30214211

APA Style

Mostovaya, O., Vavilova, A., Gazizova, A., & Stoikov, I. (2025). Cyclophane-Based Dendrimers: Today and Tomorrow. Molecules, 30(21), 4211. https://doi.org/10.3390/molecules30214211

Article Metrics

Back to TopTop